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Abstract
Ryanodine receptors (RyRs) are intracellular homotetrameric Ca
2
+-release
channels constituting a family of three different isoforms, named RyRl, RyR2
and RyR3. RyRl and RyR2 are highly expressed in skeletal and cardiac
muscles respectively, where they localize in the terminal cisternae of the
sarcoplasmic reticulum (SR). Although RyRl and RyR2 have been found to be
expressed in several other tissues at much lower level than in striated muscles,
their major functional role is related to Ca2+-release from the SR following
electrical depolarization of the plasma membrane, a process referred to as
excitation-contraction (e-c) coupling and known to regulate striated muscle
contraction.
The third isoform, RyR3, is characterized by a wide pattern of expression,
without any specific association to a tissue or a cell-type. The finding that
RyR3 is also expressed in mammalian skeletal muscles parallels the presence of
two distinct isoforms, o- and P-RyR, in non-mammalian vertebrate skeletal
muscles, and suggests that two functionally distinct RyRs may be involved in
the regulation of skeletal muscle contraction.
The expression of RyR3 was analyzed in murine skeletal muscle from late
foetal stages to adult, throughout neonatal phases of development. RyR3 was
expressed widely during skeletal muscle post-natal development, disappearing
in all muscles analyzed except diaphragm and soleus.
RyR3 knockout mice were generated, and contractile properties of skeletal
muscles were analyzed. Skeletal muscle contraction in RyR3-/- mice was
impaired during the neonatal phase of development. In skeletal muscles isolated
from RyR3-1- mice, the twitch elicited by electrical stimulation was strongly
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depressed. A significant reduction of the contractile activity was also elicited
after stimulation with caffeine, an activator of Ca2+-release through RyRs. In the
adults, no differences were detected between wild-type and mutant mice.
These results are the first demonstrations of a physiological role of RyR3 in
excitation-contraction coupling mechanisms of skeletal muscle, and support the
model of a two-channel system regulating skeletal muscle contraction.
In order to further characterize the RyR3-1- mouse, [3H]ryanodine binding
experiments were performed on diaphragm and total hindlimb skeletal muscles
from RyR3+/+ and RyR3-1- mice. Preliminary results will be presented and
discussed.
2
Introduction
Chapter 1
1.1. Ryanodine Receptors
1.2. The striated muscle system
pg4
pg27
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1.1. Ryanodine Receptors.
4
1.1.1. Intracellular calcium signalling.
Cellular signalling mechanisms allow the transmission of information from the
cell surface membrane to specific targets within the cell. The transmission
occurs via intracellular messengers, of which the calcium ion, Ca2+, is one of the
most important.
Ca2+ is ubiquitously distributed and controls a wide array of cellular processes
as diverse as secretion, cell proliferation, contraction, learning and memory
(Berridge, 1993; Berridge et al., 1998).
In resting cells, the intracellular Ca2+ concentration appears to vary between 10
and 100nM. During stimulation, [Ca2+Ji can rise up to several micromolar
values, depending on the cell type.
The versatility of Ca2+ signals counts for all the different processes in which it is
involved: Ca2+ can operate in small cellular compartments, pervade the entire
cytoplasm, or penetrate organelles such as mitochondria and the nucleus. In
addition, the duration of Ca2+ signals spans from microseconds to hours, and it
can be in a transient or in a pulsatile manner. As a consequence, the signals
achieved by the cell vary in localization, kinetics, amplitude and frequency.
Cells use two sources of Ca2+ for generating signals: Ca2+ entry from the outside
through the plasma membrane and Ca2+ -release from intracellular stores such as
the endoplasmic reticulum (ER) or sarcoplasmic reticulum (SR), using either
inositol 1, 4, 5-trisphosphate receptors (InsP3Rs) or ryanodine receptors
(RyRs).
Both Ca2+-release and Ca2+ -entry channels, once activated, introduce brief pulses
of Ca2+ in the cytoplasm, known as "elementary" Ca2+ signals, that represent the
basic building blocks of Ca2+ signaling (Bootman and Berridge, 1995). These
elementary events result from the opening of individual or small groups of
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channels on the internal stores. The openings of individual channels or small
groups of channels are fundamental events referred to as "blip" and "puffs",
respectively, in the case of the InsP:1receptors or "quark" and "sparks" in the
case of the RyRs. The elementary Ca2+ signaling units can either activate highly
localized cellular processes in the immediate vicinity of the channels, or
generate global Ca2+ signals as waves and oscillations by recruiting channels
throughout the cell (Bootman and Berridge, 1995; Bootman et aI., 1997;
Berridge et aI., 1999).
Many processes are directly controlled by local Ca2+ signals, like the release of
synaptic and secretory vesicles, or the activation of ion channels. Such
elementary signals produce a high localized, specific and rapid effect at
relatively low cost to the cell compared to global Ca2+ changes.
An example of a Ca2+ wave spreading in a regenerative way is represented by
the Ca2+ -induced Ca2+ -release (CICR) mechanism, used by both non-excitable
and excitable cells. In this case, an elementary Ca2+ signal in one region of the
cell provides a pulse of Ca2+ that stimulates the neighbouring channels,
triggering to global Ca2+ signaling (Fig.l.l).
In the specific case of myocytes of cardiac muscle, activated voltage-operating
channels recruit clusters of ryanodine receptors that produce a spark (Cheng et
aI., 1993). The activation of many spark-sites in each myocyte increases the
global Ca2+ levels in the cardiac cells, triggering the contraction.
The existence of local and global signalling modes is a great advantage for the
cells, because Ca2+ can be used to control separate processes in the same cell,
depending on how it is presented. In smooth muscle cells, Ca2+ sparks located
near the plasma membrane activates Cai'-sensitive K+channels to give outward
currents that cause muscle relaxation by hyperpolarization of the cell membrane
(Nelson et aI, 1995). On the other hand, a global Ca2+ wave generated by
coordinated Ca2+ sparks triggers muscle contraction. Thus, Ca2+ can control
6
Cell membrane
'. •Calcium ." , ,. "spark __. •• ,. •. .,...
••••• • •..'..
Global calcium
Calcium
." . '.· .".• • •• ••spark __. •••••• ••••..'. ,RyR
contraction
Figure 1.1. Local and global Ca2+ signalling. Groups of ryanodine receptors
(RyRs) located on the membrane of the sarcoplasmic reticulum (SR) release
localized bursts of of Ca2+ , giving rise to elementary events called "sparks".The
sparks contribute to the global calcium signalling, producing contractioon.
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both muscle relaxation and contraction, depending on whether it is presented as
elementary or global Ca2+ signal.
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1.1.2. Inositol I, 4, 5-trisphosphate receptors (InsP3Rs).
The InsP3 and ryanodine receptors constitute the two principal intracellular
Ca2+ channels that mobilize Ca2+ from intracellular stores as a response to
external signals. These two types of receptors share similar structural and
functional homologies.
The InsP3 receptor has a tetrameric structure with -300 kD subunits. It contains
typical membrane-spanning domains in the C-terminal region, anchoring the
protein to the membrane of the intracellular Ca2+ store. The large N-terminal
domain lies free in the cytoplasm, containing the InsP3 binding site at its end.
The existence of three different genes for InsP3Rs, together with alternative
splicings, contributes to the heterogeneity of InsP3 receptor family (Berridge,
1993).
The different isoforms of InsP3Rs are expressed in a tissue- and development-
specific manner, and can form homo- and heterotetrameric channels (Newton et
aI., 1994; Monkawa et aI., 1995; Dent et aI., 1996). Thus, the complex
expression pattern may be responsible for the generation of cell type-specific
Ca2+ signalling. The relation between the differential expression of InsP3R
subtypes and different Ca2+ signalling patterns has been studied using
genetically engineered B cells, expressing either a single or a combination of
InsP3Rs subtypes (Miyakawa et aI., 1999). This analysis reveals that different
Ca2+ signalling patterns are encoded by differential expression of InsP3R
subtypes, which differ in their response to intracellular agonists such as InsP3,
ATP and Ca2+.
The InsP
3
R activity is modulated by Ca2+: first the endogenous ligand InsP3
binds the receptor in the N-terminal domain of a single subunit, determining a
conformational change that expose a Ca2+ binding site. Ca2+ binding provokes a
slow inhibition of channel opening (Taylor, 1998).
9
Furthermore, InsPJRs are modulated by accessory proteins like ankyrin,
calmodulin and FKBP12 (Taylor, 1998).
InsP3, the endogenous ligand, can be released by two different receptor classes,
the G protein-coupled receptor class (GPRs), and the receptor tyrosine kinases
(RTKs). While GERs activate phospholipase C~ (PLC~), RTKs stimulate
phospholipase Cy (PLCy), converting in both cases phosphatidylinositol (4,5)-
bisphosphate into InsP3 and diacylglycerol (DG). InsP3 binds to the tetrameric
InsP3 receptor triggering Ca2+-release from the endoplasmic reticulum.
(Berridge, 1993; Clapham, 1995).
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1.1.3. The ryanodine receptor family.
The RyRs are intracellular Ca2+ -release channels originally described in the SR
of skeletal and cardiac muscle (Fleischer and Inui, 1989). They were named
ryanodine receptors because of their ability to bind the plant alkaloid
ryanodine.
The vertebrate RyRs identified to date are homotetramers composed of
polypeptide subunits with molecular mass of 500-600 kD, encoded by mRNAs
with masses in excess of 15 kb. The ion channel-forming portions of the
receptor molecules are constituted by membrane-spanning regions localized in
the COOH-terminal of the protein. The RyR channel domains have not been
completely defined and has been suggested to consist of either 4 (Takeshima et
al., 1989) or 10 (Zorzato et al., 1990) trans-membrane domains (TM). The
remaining NH2-termina1 parts of the RyR comprise -80% of the protein mass,
and form large cytoplasmic foot-domains that are quaterfoil in arrangement
(Wagenknecht and Radermacher, 1995).
Figure 1.2 shows a ryanodine receptor scheme.
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cytosol
lumen
COOH
Figure 1.2. Schematic model of ryanodine receptor. Figure represents
the tetrameric structure of the channel with the large N-terminal region
in the cytosol, ten trans-membrane (according to Zorzato et aI., 1990) and
the very short C-tenninal tail in the cytosol. Divergent regions Dl and D2
are indicated. The divergent region D3 is represented by the pink loops
between TM3 and TM4, and between TM4 and TM5.
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The RyRs comprise a family of proteins. cDNAs for three RyRs have been
cloned and sequenced from mammalian tissues. They are encoded by three
separate genes: RyRJ expressed especially in skeletal muscle (Takeshima et aI.,
1989; Marks at al., 1989; Otsu et al, 1990; Zorzato et al., 1990), RyR2 abundant
in cardiac muscle (Nakai et al., 1990; Otsu et aI., 1990), and RyR3 initially
identified in brain (Hakamata et al., 1992) and in a mink lung epithelial cell line
(Giannini et al., 1992).
cDNA for rabbit RyRI encodes a protein of 5037 amino acids and shares 66%
homology with cDNA for rabbit RyR2 that encodes a protein of 4969 amino
acids (Sorrentino, 1995). cDNA for mink RyR3 encodes a protein of 4859
amino acids, and reveals an identity of 66% and 70% to rabbit RyRI and RyR2,
respectively (Marziali et aI., 1996).
Despite the high degree of homology among the three RyRs isoforms, there are
at least three regions where the amino acid sequences diverge significantly. The
first divergent region, named Dl, is the least conserved: it spans between
residues 4254 and 4631 of RyRl (and corresponding residues of RyR2 and
RyR3), includes the intralumenal loop between the transmembrane domain 3
(TM3) and 4 (TM4), and a larger cytoplasmic loop between TM4 and TM5
(Figure 1.2). Two other smaller regions present a diversification at the level of
amino acid sequences between the different isoforms. They are the region D2
between residues 1302-1404 of RyRI and region D3 between residues 1872-
1923 of RyRl and the corresponding regions of RyR2 and RyR3.
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1.1.4. Potential regulatory domains
The primary amino acid sequence of RyRs suggests the presence of potential
sites of interaction for modulators of channel activity, such as adenine
nucleotides, Ca2+, calmodulin and protein kinases.
Several sites for calmodulin-dependent protein kinase (CaM kinase) and
cAMP-dependent protein kinase (PKA) have been found in the RyR amino acid
sequence, and experimental evidence has shown that CaM kinase preferentially
phosphorylates the serine 2809 (Ser2809) in the RyR2 (Witcher et aI., 1991). The
corresponding site in RyRl (Ser2843) is phosphorylated by cAMP-, cGMP- and
CaM protein kinases (Suko et aI., 1993).
Potential binding sites for Ca2+, ATP and calmodulin were predicted in the
region between residues 4253-4499 of the rabbit RyRl (Takeshima et aI., 1989;
Zorzato et aI., 1990). Antibodies against region 4445-4586 influence the
channel activity of RyRl, as well as a second antibody against the peptide
sequence PEPEPEPEPE, corresponding to amino acids 4489-4499 (Sorrentino,
1995).
Calmodulin binding at several predicted binding sites has also been
demonstrated in the rabbit RyR1 (Chen and MacLennan, 1994).
Several potential ATP binding sites are present on each RyR isoform. A region
at the C-terminal portion of the molecule seems to contain ATP binding sites,
as well as the ryanodine binding site (Sorrentino, 1995).
Another potential regulatory domain has been localized in the region around
arginine 615 (Arg615). A single point mutation at nucleotide 1843 (changing C
to T) substitutes a Cys for Arg615, and has been identified as the possible cause
of malignant hyperthermia in swine and human, an inherited genetic myopathy
triggered by some volatile anaesthetics (MacLennan and Phillips, 1992).
1.1
1.1.5. Alternative splice variants of RyRs.
Further heterogeneity in the RyR family is achieved by alternative splicing of
mRNA. Two alternative splice sites have been found in human and mouse
RyRI mRNA. In the human RyRI cDNA, two insertions of 5 amino acids after
residue 3489 and of 6 amino acids after residue 3864 have been detected
(Zhang et aI., 1993). In the mouse and rabbit RyRl cDNA, two similar
insertions at the same amino acid position were reported (Futatsugi et aI., 1995;
Zorzato et aI., 1990). Because the 5 and 6 amino acid insertions occur in the
region of RyRl containing putative binding sites for channel modifiers, such as
Ca2+, calmodulin, ATP, and the serine residue (Ser2843) that is phosphorylated
by the CaM and the cAMP-dependent protein kinase (PKA), it was suggested
that these splice events may alter RyRl function. The possibility that the
resulting RyRl proteins have unique functional roles is supported by the co-
expression of the splice variants in the same tissues (skeletal muscle and brain),
and the existence of the same variants in human, mouse and rabbit muscles,
indicating the conservation in different species (Sutko and Airey, 1996).
An alternative splicing site involving a 24 bp segment encoding amino acids
3716-3723 has been identified in rabbit RyR2 (Nakai et aI., 1990), and three
alternative splicing sites have been identified in the mink RyR3 cDNA
(Marziali et aI., 1996). The first two alternative splicing sites consist of
insertion of 5 amino acids after residue 3335 and of 6 amino acids after residue
3710. Similar alternative splicing regions have been observed in human, mouse
and rabbit (see above). The third splicing site is defined as a mutually exclusive
splicing mechanism, in which one out of two exons can be alternatively
included in the mature RyR3 mRNA. The region involved in this splicing
mechanism spans residues 3495-3527.
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Similar to RyRl, alternative splicing sites identified in RyR2 and RyR3 are in a
region containing many potential regulatory sites, such as the modulatory
region upstream the transmembrane domains. The existence of alternatively
spliced variants and, as a possible consequence, of proteins with unique
functional properties, may result in further heterogeneity in the Ca
2
+ -release
properties of RyRs.
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1.1.6. Modulators of RyRs activity
Ryanodine receptors activity can be modulated by several factors, both
endogenous and exogenous. Some of these agents have a crucial role in the
opening or closing of the channel, while others seem to modulate RyR
sensitivity to Ca2+.
Regulation of the RyR channels has been studied in vitro using different
techniques: Ca2+ fluxes measured in SR vesicles; single channel recordings
following the incorporation of SR vesicles or purified channels into planar lipid
bilayers; [3H]ryanodine binding studies, using ryanodine as ligand to probe the
functional states of the release channel. The following description is a summary
of results obtained with these different experimental approaches.
1.1.6a. Ca2+
Ca2+ is one of the main regulators of ryanodine receptors, able to activate or
inhibit Ca2+-release. In fact, Ca2+-induced Ca2+-release (CICR), the primary
activation mechanism for sarcoplasmic reticulum Ca2+ -release in cardiac muscle
(Fabiato, 1983), seems to be a general property of RyRs (see below). RyR Ca2+-
dependence shows a bell-shaped activation curve, with channel opening
stimulated by Ca2+ in the micromolar range, while Ca2+ concentration close to
the millimolar range exerts an inhibitory effect (Meissner, 1994; Coronado et
al., 1994). These experiments were usually performed on permeabilized muscle
fibers, SR vesicles, or purified RyRs incorporated into lipid bilayers
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1.1.6b. Mg2+and adenine nucleotides.
Mg2+ in the millimolar range produces a strong inhibition of Ca-release
through RyRs, via a mechanism of competitive antagonism for the Ca2+ high-
affinity activation sites (Meissner et aI., 1994; Murayama et aI., 1998).
Several adenine nucleotides, such as, ATP, ADP, AMP, cAMP, AMP-PCP,
adenosine, adenine, potentiate Ca2+ release through RyRs, counteracting the
inhibition by Mg2+(Meissner et aI., 1994).
1.1.6c. Ryanodine.
Ryanodine has been shown to exert a concentration-dependent effect on RyR
channel activity: at concentrations in the range of O.Ol-10~M Ca2+ release is
stimulated, whereas at higher concentrations release is inhibited (Coronado et
aI., 1994).
In addition, because ryanodine is a specific ligand for RyRs, analysis of
ryanodine binding provides precious information about channel function. Many
studies of [3H]ryanodine binding have been performed on skeletal and cardiac
sarcoplasmic reticulum, as well as on purified receptors from the same tissues.
[3H]ryanodine binding experiments have also been performed on other tissues
such as brain, smooth muscle, liver and epithelial cells (Coronado et aI., 1994
and references inside). Ryanodine binds preferentially to the open state of the
receptors. This is suggested by the fact that ligands known to open the channel
and stimulate Ca2+ release (micromolar Ca2+ or millimolar ATP), stimulate
[3H]ryanodine binding. By contrast, ligands known to close the channel and
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inhibit Ca'l-releasc (micromolar ruthenium red and millimolar Mg2+) inhibit
[3H]ryanodine binding.
[3H]ryanodine binding is strictly Ca2+ dependent: binding to skeletal receptor
has a Ca2+ threshold ofO.I-I/lM, the maximum at IO-IOO/lM and is inhibited at
Ca2+ concentration> ImM. The bell-shaped Ca2+ dependence of [3H]ryanodine
binding is similar to that obtained with Ca2+ flux experiments.
[3H]ryanodine binding to the cardiac isoform has a Ca2+ threshold -1/lM, is
optimal in the range IO/lM-lmM but is little inhibited at high Ca2+
concentrations.
Caffeine in the molar range stimulates [3H]ryanodine binding to the skeletal
receptor, and, to a lesser extent, to the cardiac receptor. Adenine nucleotides in
millimolar concentration stimulate [3H]ryanodine binding to the skeletal
receptor, but have little effect on the cardiac isoform. Increasing pH,
temperature and KCI or NaCI stimulates [3H]ryanodine binding to both skeletal
and cardiac isoforms.
[3H]ryanodine binding to skeletal receptor, but not to cardiac receptor, is
inhibited by Mg2+in the millimolar range, while ruthenium red in nanomolar
concentration inhibits the binding to the two isoforms (Coronado et aI., 1994
and references therein).
At variance with the large number of studies performed on skeletal and cardiac
channels, [3H]ryanodine binding experiments on RyR3 were recently
performed on the receptor purified from rabbit and bovine diaphragm
(Murayama and Ogawa, 1997; Jeyakumar et aI., 1998). The Ca2+ dependence
experiments show that RyR3 is about 7-fold less sensitive to Ca2+ compared to
RyRl. RyR3 results more resistant to Mg2+inhibition than RyRI, while binding
is strongly inhibited by ruthenium red and procaine. Activators of RyRs such as
caffeine and AMP-PCP, a nonhydrolyzable ATP analogue, increase
[3H]ryanodine binding to RyR3. Contrasting results have been obtained on
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micro somes from mouse parotid acini, containing only RyR3: Mg2+, together
with ruthenium red, was shown to strongly inhibit ryanodine binding to RyR3,
while ATP and caffeine were much less efficient as activators (DiJulio et aI.,
1997)
1.1.6d. Caffeine
Caffeine has been used as a pharmacological agent to stimulate RyR opening.
The Ca2+-release activity of RyR channels treated with caffeine in the
millimolar range displays a bell-shaped dependence as that shown by untreated
channels. Caffeine increases the sensitivity of RyRs to Ca2+, prolonging the
duration of open channel events (Berridge et aI., 1995).
The three isoforms seem to have different sensitivities to caffeine, with the
cardiac isoform, RyR2, being the most sensitive, followed by the skeletal
muscle isoform, RyRl, and then by RyR3 (Berridge et aI., 1995; Takeshima et
aI., 1995; Chen et aI., 1997).
1.1.6e. Cyclic adenosine 5'-dipbospboribose (cADPR).
Ca2+-release through RyRs can be activated by cyclic ADP-ribose (cADPR), a
Ubiquitous metabolite of nicotinamide adenine dinucleotide (NAD+) (Galione,
1993). cADPR was first discovered studying Ca2+-release from microsomes
derived from the endoplasmic reticulum of sea urchin eggs after addiction of
NAD+ (Dargie et aI., 1990). A several minute latency period suggested that
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NAD+ was converted into an active metabolite, identified as cADPR. cADPR
mobilizes Ca
2
+ by a mechanism completely independent of the IP3 receptors as
demonstrated by desensitization studies and by the use of channel antagonists.
In fact, after Ca
2
+-release by cADPR microsomes were desensitized to further
release by an additional dose of cADPR, but they remained sensitive to Ca2+_
release by IP3. On the contrary, IP3-induced Ca2+-release desensitized
microsomes to subsequent release by IP3, but not by cADPR. Secondly, the IP3
antagonist heparin inhibits Ca2+-release by IP3 but has no effect on cADPR-
induced Ca
2
+-release (Galione and Summerhill, 1995). Desensitization studies
with known RyR antagonists showed that cADPR releases Ca2+via a ryanodine-
sensitive CICR mechanism (Galione et al., 1991). In fact, after Ca2+-release by
ryanodine or caffeine cADPR can not elicit further Ca2+-release, while IP3 is
still able to induce Ca2+-release. Conversely, after Ca2+-release by cADPR, the
stores are insensitive to further release by cADPR, caffeine or ryanodine, while
they are still sensitive to IP3. In addition, RyR blockers such as ruthenium red
and procaine block cADPR-induced Ca2+-release. The Ca2+-release activity of
cADPR is also stimulated by calmodulin (CaM) and Ca2+ (Lee, 1995; Galione
and Summerhill, 1995). Taken together, these results support the hypothesis
that cADPR is an endogenous modulator of CICR through RyRs. In addition to
sea urchin eggs, cADPR has been shown to have Ca2+ mobilizing activity in
many other cells, including mammalian and amphibian cells (Lee, 1995),
however, it is not clear yet whether cADPR works as a second messenger for
extracellular stimuli. In the standard messenger model, the activation signal
(induction of Ca
2
+-release) would come from a ligand-induced increase in the
intracellular concentration of cADPR. The main problem in investigating if
cADPR could be a second messenger comes from the technical difficulties in
measuring changes in intracellular cADPR concentration. In the alternative
modulator model, the activation signal would come from the increase in
,..,.
intracellular Ca2+ concentration without the necessity of an elevation of cADPR
concentration.
Although the ability of cADPR to activate Ca2+-release through RyRs is well
established, the interaction between cADPR and mammalian RyRs is highly
debated (Lee, 1997). In fact, while Meszaros et al. (1993) reported the
activation by cADPR of Ca2+-release through RyR2 but not RyRl, Williams and
co-workers reported cADPR-induced Ca2+-release through RyRI (Sitsapesan et
aI., 1995). Recent experiments of single-channel recordings with bovine muscle
preparations and muscle micro somes from normal and RyR3 knockout mice
(Bertocchini et aI., 1997) indicate that cADPR stimulate Ca
2
+-release also
through RyR3, while RyRI were insensitive (Sonnleitner et aI., 1998).
1.1.7 Ryanodine receptor- FKBP12 interaction.
Ryanodine receptor type 1 is associated with a -12 kD protein, named FKBPI2,
with which it co-purifies and co-localizes in the junctional SR of skeletal
muscle (Collins, 1991; Jayaraman et al. 1992). FKBPI2, or FK506 binding
protein, is a member of the immunophilin family, ubiquitously expressed
proteins that are cytosolic repressors of immunosuppressing drugs (FK506,
rapamycin). One FKBP12 is bound to each subunit of the four subunit of the
RyR, with a molar ratio of FKBP to RyR of 1:1. A cardiac isoform of FKBP12,
named FKB 12.6 is selectively associated with the cardiac RyR isoform with the
same molar ratio of 1:I (Timerman et aI., 1994; Lam et aI., 1995). By treatment
with drug FK506, FKBPs can be dissociated from RyRI or RyR2, but, while
RyR2 can rebind only FKBPI2.6, RyRI can associate with both FKBPs.
Recently, binding sites for both FKBPl2 and FKBPI2.6 have been identified
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on RyR3. Experiments on purified RyRl free from FKBP12 demonstrated a
stabilization effect ofFKBP12 on RyRl activity (Brillantes et al., 1994).
1.1.8 RyR pattern of expression
As discussed above, RyRl and RyR2 playa fundamental role for the release of
Ca2+ from the SR of skeletal and cardiac muscles, where they are respectively
expressed at very high levels. RyR3 was originally found to be expressed in
many tissues at low levels, but without a preferential association to specific cell
types or tissues (Giannini et al., 1992).
A wide analysis of RyR expression III mammals has been performed by
different techniques such as RNAse protection, in situ hybridization and
immunohistochemistry (Nori et al., 1995).
Experiments of RNAse protection on adult mouse tissues confirmed the high
level of expression of RyRl and RyR2 in skeletal and cardiac muscle
respectively; in addition they revealed a spread distribution of the two isoforms
in many more tissues, which goes together with the large distribution of RyR3
(Giannini et aI., 1995). Particularly interesting is RyR expression in brain and
muscle systems (smooth, cardiac and skeletal muscle).
All three isoforms are expressed in brain, even though they cover different
areas. In situ hybridization on adult mouse brain (Giannini et al., 1995) and
adult rabbit brain (Furuichi et al., 1994) confirmed RyR2 as the predominant
brain isoform (McPherson and Campbell, 1993), and showed a heterogeneous
distribution of the three receptors in different areas of brain. These results were
also supported by immunohistochemistry experiments. Table 1 summarizes the
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pattern of expression of RyR isoforms in different region of the brain (from
Nori et al., 1995).
RNAse protection and in situ hybridization revealed that RyR3 is expressed in
organs containing smooth muscle, such as aorta, esophagus, urinary bladder,
spleen, lung, kidney (Hakamata et al., 1992; Giannini et al., 1995). Very low
levels of RyRl and RyR2 mRNA have also been detected in some tissues such
as aorta, stomach and spleen (RYR1). Recently, RyRs have been localized in
aortic and vas deferens smooth muscle using immunofluorescence confocal
microscopy and immunoelectron microscopy (Lesh et al., 1998).
RyR expression in mammalian striated muscles is characterized by the high
level of RyRI in skeletal muscle and RyR2 in cardiac muscle, with the absence
of expression of RyRI and RyR2 from cardiac and skeletal muscle,
respectively. The third isoform, RyR3, is expressed in the conduction myocytes
of the heart and in skeletal muscles, as revealed by RNAse protection
experiments (Giannini et al., 1992; Giannini et al., 1995).
RyR3 protein expression in skeletal muscles has been deeply investigated
(Conti et al., 1996). Western blot assays on skeletal muscle microsomes from
different mammalian vertebrates (bovine, rat and rabbit) show relatively high
levels of RyR3 in diaphragm and a lower level of expression in soleus muscle.
A very weak expression has also been detected in tibialis anterior muscle.
These experiments also confirmed the high amount of RyRI in all the skeletal
muscles analyzed, and the lack of RyR2. Similarly to RyRI and the Ca
2
+-
binding protein calsequestrin, RyR3 was localized in the terminal-cisternae
region of SR, a region involved in the Ca2+ -release mechanism in relation to
contraction.
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1.1.9 Non-mammalian vertebrate RyR isoforms
RyRs have also been identified in non-mammalian vertebrates such as birds,
amphibians, reptiles and fish. Two RyR isoforms, named a and ~, have been
found in avian, amphibian and piscine skeletal muscle (Sutko and Airey, 1996).
These two isoforms have also been found in two reptilian orders, turtles and
alligators, while two other orders, lizards and snakes, express only the
a isoform (O'Brien et al., 1993). A third isoform has been localized in the avian
heart.
The avian isoforms have been isolated, purified and the ion channel properties
studied (Airey et al., 1990; Airey et al., 1993; Percival et al., 1994). The two
RyR isoforms of fish (blue marlin and toadfish) and amphibian (bullfrog)
skeletal muscles have been isolated and the ion channel properties analyzed
(Murayama and Ogawa, 1992; O'Brien et al., 1995). The mRNAs for the
amphibian and avian a- and ~-RyRs have been cloned and sequenced
(Oyamada et al., 1994; Ottini et al., 1996). a- and ~-RyRs have been shown to
be the mammalian homologous of RyRl and RyR3.
In contrast with RyR expression in mammalian skeletal muscles, in most
skeletal muscles from birds and fish both exand ~ isoforms are expressed at a
comparable level. Expression of the a-RyR alone has been demonstrated in
muscles with very fast contracting properties, including the toadfish
swimbladder muscle, extraocular muscles from toadish, chickens and cats, and
the rattler muscle from rattlesnakes (O'Brien et al., 1993). The differential
expression of RyR isoforms in non-mammalian vertebrate specialized muscles
appears to be a way to regulate Ca2+ release in relation to particular contractile
properties of those muscles.
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1.1.10. Invertebrate ryanodine receptors
A ryanodine receptor has been cloned in Drosophila melanogaster (Takeshima
et aI., 1994). The derived amino acid sequence reveals <50% homology with
mammalian isoforms. The Drosophila protein has not been isolated and
characterized yet. RyRs have been identified in other invertebrates (Sutko and
Airey, 1996), by ultrastructure analysis, ryanodine effects on function,
[3H]ryanodine binding and lipid bilayer studies. These RyRs have yet to be
characterized at a molecular level.
?f..
1.2. The striated muscle system
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As discussed in the first part of this introduction, Ca1+ signalling plays a
fundamental role in the regulation of many different cellular functions, and
intracellular Ca
2
+ stores are very important in the regulation of intracellular Ca2+
concentration. The storage and release of Ca2+ from the SR of striated muscle,
and its role in muscle contraction represents an example of such regulation.
In striated muscles, contraction is activated by Ca2+ released from cytoplasmic
stores in response to depolarization of the surface membrane. This process is
called excitation-contraction (e-c) coupling, and takes place at intracellular
junction between the plasma membrane or its invagination, the transverse (T)
tubules, and the internal Ca2+ stores of the sarcoplasmic reticulum (SR) (Fig.
2.1). The junctions are named triads, dyads or peripheral couplings, depending
on the number and structure of their components. Triads and dyads consist of
two SR cisternae or one SR cisterna, respectively, in contact with one T tubule,
while in peripheral couplings SR cisternae make contact directly with the
plasma membrane (Flucher and Franzini-Armstrong, 1996). These junctions are
all equivalent to each other in their composition and function in e-c coupling
mechanism. Junctions between the SR and the T tubule have two preferred
orientation: transverse or longitudinal. In the transverse orientation, the facing
membranes lie in planes transverse to the fiber long axis; in the longitudinal,
they lie in planes parallel to fiber long axis. Transversely oriented triads are
typical of vertebrate twitch fibers, while longitudinal triads and dyads are in
some vertebrate slow tonic fibers and in most fibers from invertebrates. The T-
tubule network can be localized at the Z line or at the A-I junctions, resulting in
one or two T-tubules per sarcomere. All known mammalian twitch fibers have
two T-tubules per sarcomere.
The mechanism of e-c coupling is based on the presence of a "Voltage sensor"
located in the T tubule that responds to depolarization by gating Ca'-release
from the Ca2+ channels localized in the SR.
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The molecular basis of this mechanism involves a voltage-dependent Ca2+
channel of L-type named dihydropyridine receptor (DHPR) as voltage sensor
on the T tubule, and the RyR as the Ca'l-release channel on SR. Although in
both skeletal and cardiac muscles the activation of the SR Ca2+ -release channel
is under the tight control of DHPR, the mechanism of e-c coupling differs in the
two muscle types. These two different mechanisms will be described in details
in the following sections.
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Figure 2.1. A) Frog sartorius muscle. B) Schematic representation of muscle
in A. The T-tubule with the two adjacent enlargments ofSR (terminal cisternae)
form the triad.
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1.2.1 L-type Ca2+ channels.
L-type Ca2+ channels, indicated also DHPRs because of the ability to bind the
pharmacological agents dihydropyridines (DHPs), are slowly activating Ca2+
channels responsible for charge movement across the T-tubule associated with
depolarization.
DHPRs are composed of five subunits, aI, a2, ~, y, 8 (Fig. 2.2) (Catterall,
1991). Three gene families are known to exist for the L-type Ca2+ channels, the
skeletal type, expressed at high levels only in skeletal muscle; the cardiac type,
expressed in heart, brain and some other tissues; the class D type expressed in
neural and endocrine tissues (Tanabe et aI., 1987; Mikami et aI., 1989). The (XI
subunit is the functional component of the complex (Fig. 2.3). It contains four
homologous domains with six trans-membrane segments in each, and is the
Ca2+ channel forming and the DHP-binding portion of the molecule. The role of
(X I subunit in e-c coupling has been established by the use of dysgenic mice.
Muscular dysgenesis is a recessive lethal disease due to a point mutation in the
(Xl subunit gene, resulting in undetectable levels of the protein. The interruption
of e-c coupling in dysgenic fibers and the rescue of functions in fibers
transfected with (XI cDNA provided the evidence leading to the identification of
DHPR as the e-c coupling "voltage sensor" (Tanabe et aI., 1988, 1990a; Adams
et aI., 1990).
The ~I subunit modulates the L-type Ca2+ current and it is proposed to modulate
the number of (XI subunit in the membrane (Strube et al., 1996). The role of the
other subunits is not clear yet.
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Ca2+
Figure 2.2. Subunit structure ofDHPR
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Figure 2.3. <xl subunit ofDHPR. I, II, III, IV represent the four homologous
domaind with the six trans-membrane segments in each.
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1.2.2. The e-c coupling in skeletal muscle
The mechanism of e-c coupling in skeletal muscle, also named voltage-
dependent Ca2+-release (Schneider and Chandler, 1973), is based on a
mechanical coupling between the surface/t-tubular membrane protein, DHPR,
and the Ca2+-release channel on the SR membrane, RyR. The depolarization
causes the DHPR to undergo a conformational change that leads to the
activation of the RyR channel (Fig. 2.4A). In skeletal muscle, Ca
2
+-current
through DHPR is slow and not required to trigger SR Ca
2
+-release. This
mechanism is also named voltage-dependent, Ca2+-independent Ca
2
+-release, or
directly coupled Ca2+-release (DCCR). DHPR works as a voltage sensor
controlling the opening of RyRs via supposed molecular interactions. The
mechanism of mechanical coupling, that is how a change in DHPR
conformation is transmitted to the RyR, is not yet known. One possibility is that
DHPR interacts directly with RyR. This direct molecular interaction between
DHPR and RyR is supported by several kinds of observations. The cytoplasmic
loop between repeats II and III of <XI-DHPRsubunit is required for activation of
SR Ca2+-release in dysgenic mouse cultured skeletal muscle cells by DCCR
(Tanabe et al., 1990a; Tanabe et aI., 1990b). Neither the intact cardiac DHPR
nor a chimeric skeletal muscle DHPR containing the cardiac II-III loop was
able to support DCCR. This evidence also shows that the type of e-c coupling,
skeletal or cardiac, is determined by the DHPR isoform present in the cell,
because transfection in cultured skeletal muscle cells from dysgenic mice with
cDNA for cardiac DHPR (<X2-DHPR)results in cardiac-type e-c coupling (see
below) (Tanabe et al., 1990b). Actually, the RyR isoform also plays its role in
determining the e-c coupling type, in fact peptides containing the skeletal II-III
loop region have no effect on RyR2 (Lu et aI., 1995). Experiments with
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transgenic mice lacking RyR1 confirm a role of RyR isoforms in determining
the e-c coupling type (see below).
In addition, a complex containing DHPR and RyR was precipitated by either
anti-DHPR or anti-RyR antibodies (Marty et al., 1994). A second possibility
would be that DHPR and RyR do not interact directly, as suggested by
unsuccessful attempts to chemically crosslink these two proteins (Caswell and
Brandt, 1989). An interaction between DHPR and RyR could be mediated by
other proteins. The search for an intermediary protein led to the discovery of an
integral protein of the SR membrane, named triadin (Brandt et al., 1990; Kim et
al., 1990; Caswell et al., 1991). Triadin is a 95 kD protein enriched in the
junctional SR (jSR) and absent from the longitudinal SR. Three triadin isoforms
have been detected in both muscle and cardiac muscle (Peng et a1., 1994; Guo
et al., 1996). Monoclonal antibodies against DHPR and RyR were found to
immunoprecipitate triadin (Motoike et a1., 1994). Two different interpretations
of triadin location in the junctional membrane exist. In the first model triadin
repeatedly crosses the jSR with one of its cytoplasmic loop connecting DHPRs
and RyRs (Fan et al., 1995) (Fig. 2.5). In the alternative model, triadin has a
short cytoplasmic NH2-tenninal, a single spanning membrane region and a
long, highly charged COOH-tenninal tail in the lumenal side (Guo et al., 1996)
(Fig. 2.6). In this model triadin does not participate in the DHPR-RyR link.
Rather, its lumenal region does interact with calsequestrin and RyR (Guo and
Campbell, 1995).
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Figure 2.4 A and B. The two mechanisms proposed to account for RyR
activation in skeletal muscle (A) and cardiac muscle (B).
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Figure 2.5. Triadin membrane topology. In this model triadin crosses the
mem brane 4 times. Interaction with RyR and DHPR are indicated. S-S bonds
create triadin oligomers. N- and C-terminals are in the cytosol.
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Figure 2.6. Alternative model for triadin topology. In this model triadin has
single trans-mem brane domain, a short N-terminal region in the cytosol and a
highly positive charged C-terminal region. This region would interact with
negatively charged calsequestrin and with a lumenal loop of RyR.
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1.2.3. e-c coupling in cardiac muscle
In cardiac muscle, depolarization causes the entry of Ca2+ into the cell through
DHPR. The Ca2+ current is fast and necessary for e-c coupling, triggering the
activation of Ca'-release via RyRs by a process called Cai'-induced Ca2+_
release (Fig.2.4B). The amplified Ca2+ signalling causes muscle contraction
(Fabiato, 1983, 1985; Cannell et aI., 1995). Thus, while in skeletal muscle the
e-c coupling mechanism is voltage-dependent and Cai'-independent, in cardiac
muscle Ca2+-release is triggered by a Cai'-dependent mechanism.
Although CICR is the primary activation mechanism for SR Ca2+-release in
cardiac muscle, it has also been observed in skeletal muscle. Both DCCR and
CICR mechanisms have in fact been proposed to activate Cai'-release in
skeletal muscle (Endo et aI., 1970; Rios and Pizarro, 1988; Rios and Pizarro,
1991; Jacquemond et aI., 1991; Yano et aI., 1995).
Mutant mice lacking RyR2 died at day 10 of embryonic development with
morphological abnormalities in the heart tube (Takeshima et aI., 1998).
Detailed fluorimetric analyses of Ca2+ fluxes led to propose that in embryonic
heart RyR2 is not involved in e-c coupling, but is required to control cellular
Ca2+ homeostasis, as a major leak Ca2+ channel that has a role in maintaining the
SR lumenal Ca2+ levels in the physiological range.
1.2.4 Spatial relationship between RyRs and DHPRs.
The structural organization of RyRs and DHPRs in the junctional domains
differs in skeletal and cardiac muscles, reflecting the differences between the e-
c coupling mechanisms in the two muscles. The main feature common to all
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junctions IS the "feet", electron-dense periodically distributed structures
spanning the narrow junctional gap separating the membrane of SR and either T
-tubule or plasma membrane (Franzini-Armstrong, 1970). An individual foot
appears as four equal spheres corresponding to the cytoplasmic domain of the
homotetrameric RyRs. In skeletal muscles, DHPRs are clustered in groups of
fours, or tetrads, positioned in correspondence to the feet so that each DHPR is
located in close proximity of one of the fours RyR subunit, localization that
allows a direct functional interaction between DHPR and RyR. However, the
spacing between tetrads is twice that of the feet, that is, tetrads are associated
with alternate feet, resulting in two different population of RyRs, those
associated and those not associated to DHPR (Flucher and Franzini-Armstrong,
1996). This disposition has been found in different types of fibers, and does not
depend on the presence of two different RyR isoforms (Block et aI., 1988;
Franzini-Armstrong and Kish, 1995, Flucher and Franzini-Armstrong, 1996).
The alternate disposition of tetrads over feet supports the two-component model
of Ca2+-release from SR (see below).
In cardiac muscle, DHPRs are also clustered in the junctional domains, but
neither are grouped into tetrads, nor have apparent relationship to the position
of the feet (Sun et aI., 1995; Protasi et aI., 1996). Such a disposition is in line
with the lack of a direct functional interaction of DHPRs and RyRs. However,
in cardiac muscle the concentration of DHPRs in the junctional domain
opposite to the RyRs is consistent with a CICR mechanism or cardiac e-c
coupling under the control of the L-type Ca2+ channel.
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1.2.5 RyRl knockout
Transgenic rmce derived from the targeted mutation of RyR 1 gene clearly
demonstrate a key role of RyRI as the SR Ca2+-release channel involved in the
e-c coupling machinery.
RyR 1 knockout mice die perinatally probably because of respiratory failure
(Takeshima et al., 1994). e-c coupling is lost in these mutant mice, indicating
that RyRI works as a Ca2+-re1ease channel linked to the T-tubule voltage
sensor. Electron microscopy has shown triad junction lacking feet in skeletal
muscle fibers of the so-called "dyspedic" mice (Takekura et al., 1995). In
addition, RyRI or RyR2 cDNA transfected into skeletal myoblasts from
dyspedic mice has been used in expression experiments in order to establish
which RyR type the mechanical coupling depend on (Yamazawa et al., 1996).
RyRI cDNA, but not RyR2 cDNA, was able to restore the skeletal muscle-type
coupling. The importance of RyRI isoform in the DHPR-RyR interaction was
also shown by the fact that the II-III loop had no effect on RyR2 (Lu et al.,
1995).
The "mechanical" hypothesis of skeletal muscle e-c coupling is supported also
by the retrograde signaling interaction, from RyR 1 and DHPR, revealed in
RyRI knockout mice (Nakai et al., 1996): dyspedic myotubes lacking RyRl
were shown to express greatly reduced L-type Ca2+-channels. Transfection with
RyRI cDNA re-establishes a normal situation. Thus, a retrograde signal
controls DHPR expression.
The presence of RyR3 in dyspedic mouse skeletal muscles could not
compensate the lack of RyRl, confirming the non-equivalent function covered
by RyR 1 and RyR3 in skeletal muscle (Takeshima et al., 1995).
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1.2.6. Crooked Neck Dwarf mutation (en/en).
A second animal model confirming the role of the skeletal RyR isoform in the
mechanical coupling is represented by the chicken recessive lethal mutation
Crooked Neck Dwarf (Ivanenko et aI., 1995). Although the genetic nature of
the mutation has not established, the result is the failure to make a normal a-
RyR. +I? and en/en skeletal muscle cells formed myotubes in culture, but while
+I? cells were able to switch from a Ca2+-dependent to a Ca2+-independent Ca2+_
release as observed for cultured neonatal rat skeletal muscle (Cognard et aI.,
1992), en/en were unable to operate this transition. This failure was a
confirmation that the a-RyR, the RyRl homologue, was necessary for skeletal
muscle type e-c coupling. Although en/en skeletal muscles expressed normal
levels of the I3-RyR, it was not able to support Ca2+-independent e-c coupling
and compensate for the lack of a-RyR.
1.2.7 The model of two-ryanodine receptor Ca2+-release system in
skeletal muscle.
The presence of two RyR isoforms in non-mammalian vertebrate skeletal
muscle, a and ~-RyR, and the expression, although at lower levels, of RyR3
together with RyRl in mammalian skeletal muscle, has prompted the
hypothesis of a two-RyR Ca2+-release system working in skeletal muscles, in
which some RyRs are directly activated by the DHPR in a Ca2+-independent
manner, while others would be activated by CICR as a consequence of the
activation of the first population. A two-RyR system could account for either
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specialization of the contractile function associated with different muscle fibers
or the amplification of the SR calcium release system resulting in a tune
modulation of the contraction machinery (Sutko and Airey, 1996).
Evidences in addition to the biochemical data suggest that two distinct Ca
2
+-
release channels contribute to the regulation of skeletal muscle contraction.
Electron microscopy studies (Flucher and Franzini-Armstrong, 1996),
physiological analyses of Ca2+ from the SR (Rios et al., 1992), and detection of
Ca2+ sparks in vertebrate skeletal muscles (see below) (Klein et al., 1993),
appear consistent with of the existence of a two-release channel system in
vertebrate skeletal muscles.
The model will be explained and discussed in the last part of this thesis
(Discussion), with the contribution of the reported experimental data.
1.2.S. Skeletal muscle and Caz+ sparks.
Ca2+ sparks were originally detected in quiescent rat heart cells as spontaneous
local increases in the concentration of intracellular Ca
2+, and provide an
explanation for both spontaneous and triggered changes in the intracellular Ca
2
+
concentration n the mammalian heart (Cheng et al., 1993). Ca
2
+ sparks represent
elementary events underlying e-c coupling in cardiac muscle: the opening of L-
type Ca2+ channels on the plasma membrane (DHPRs) provides a local increase
in Ca2+ concentration, that recruits RyRs via CICR (Cheng et al., 1993). If
sparks are the result of RyRs opening individually or involve several channels
opening in concert is still debated (Shirikova et al., 1999).
Ca2+ sparks have also been visualized in skeletal muscle and originate at the
level of the triad. In frog skeletal muscles, such unitary triadic ci+ -release
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events occur spontaneously by a voltage-independent mechanism, or are
initiated by the voltage sensor (Klein et al., 1996). In the latter, as a
consequence of a voltage-gated release process, a secondary activation of Ca2+-
release channels occurs, most likely via CICR activated by an increase of Ca2+
level near the release channel. These evidences, together with the equal amount
of RyRl/a and RyR3/~ in frog skeletal muscle support the two-ryanodine
receptor Ca2+ -release system suggested in the skeletal muscle e-c coupling.
Ca2+ sparks have also been detected in mammalian skeletal muscle (Conklin et
al., 1999a; Conklin et al., 1999b; Conklin et aI., 2000). Ca2+ sparks with
parameters similar to those reported for adult frog skeletal muscle have been
detected, even though at low frequency. The existence of knockout mice for
RyRI (Takeshima et al., 1994), RyR3 (Bertocchini et al., 1997) or both
isoforms (Barone et al., 1998), allowed also to analyze separately the
involvement of each isoform in the generation of Ca2+ sparks. RyRI and RyR3
are both able to generate Ca2+ sparks in the absence of the other isoform, and
they are the only intracellular Ca2+ channels that participate in sparks activity in
embryonic skeletal muscles, because null-mutant mice for both RyRI and
RyR3 abolish any production of Ca2+ sparks (Conklin et al., 2000).
1.2.9. RyR expression during muscle development.
The developmental expression of mammalian and non-mammalian vertebrate
RyRs has been investigated by Northern blot, Western blot, [3H]ryanodine
binding assay, and electron microscopy studies.
44
In chick myocardium RyRs are detected as early as embryonic day 4 (E4)
(Dutro et aI., 1993), while the classical "feet" are visible at E2.5 by electron
microscopy (Protasi et aI., 1996).
The expression of the avian (X.- and ~-RyR proteins III skeletal muscle is
differently regulated during development. The a-RyR is detected by E6 in
forming skeletal muscle cells, while the ~-RyR is detected by E17 (Sutko et aI.,
1991). At hatching, the level of RyRs increases dramatically, reaching adult
levels at day 7 (N7) posthatch. The course of expression of the RyRs and of
DHPR, measured in embryonic chicken skeletal muscle by [3H]ryanodine
binding and [3H]nitrendipine binding, evolves in parallel: the expression of
both proteins remain low before hatching and then increases (Sutko et al.,
1991).
In rat and rabbit skeletal muscles the increase of RyR expression is not initiated
until well into the period of neonatal development (Arai et aI., 1992; Brillantes
et al., 1994; Kyselovic et aI., 1994).The time of DHPR increase depends on the
species: in neonatal rat muscles the rapid increase in DHPR occurs several days
in advance of the increase of RyRs. On the contrary, DHPR and RyR mRNA
levels were found to increase in parallel during neonatal rabbit skeletal muscle
development.
A more detailed analysis of RyR expression during neonatal development was
performed on mouse diaphragm muscle (Tarroni et al., 1997). The pattern of
expression RyRI and RyR3 was investigated by Western blot assays. Both
proteins are expressed at E18, the first stage analyzed. After birth, RyRI and
RyR3 expression increases, but while RyRI increases progressively reaching
the highest level in the adult, RyR3 is expressed at the highest level from day 5
and 15 after birth, then the expression decreases. Thus RyR3 is expressed at
higher levels in neonatal than in adult diaphragm muscle.
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1.2.10 Sequential use of cardiac and skeletal e-c coupling mechanism
during skeletal muscle development.
A sequential use of DCCR and CICR for activating SR Ca2+-release has been
shown to occur in mammalian and chicken skeletal muscle developed in culture
(Cognard et aI., 1992; Strube et aI., 1994; Ivanenko et aI., 1995). Initially, SR
Ca2+-release depends on extracellular Ca2+ and becomes Ca2+-independent as
cells mature in culture. The type of e-c coupling depends on the DHPR (X-
subunit expressed in the cell. This evidence was demonstrated with the already
discussed experiments (see above) in which injection of (x, or (XrDHPR into
dysgenic myocytes resulted in the restoration of either the skeletal-type or the
cardiac-type e-c coupling mechanism, respectively (Tanabe et aI., 1990a,
1990b). The transient expression of (XI-DHPR in skeletal muscle development
and the later replacement with the skeletal DHPR isoform (Chaudhari and
Beam, 1993) justifies the transition from one e-c coupling mechanism to the
other.
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2.1. Molecular Biology techniques
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2.1.1 Competent cell preparation
XLI blu E. Coli bacterial strain (Stratagene) was used.
A single colony from a plate was picked and seeded into 5ml of Luria-Bertani
Medium (LB). It was grown at 37° oln and then diluted in 500ml LB. The
culture was grown at 37° until 108 cellslml concentration was reached. Cell
concentration was checked by measuring absorbance at 600nM wavelength
(A600) with spectrophotometer Uvikon 940 (Kontron Instruments): 108
cells/ml correspond to A600=0.5. Cells were cooled for 10 minutes (10') in ice
and then centrifuged for 10' at 6000 rpm. They were resuspended in 10ml of
sterile cold H20, diluted to 500ml and spin down again as before. The pellet
was resuspended in 200ml of sterile cold H20 and centrifuged IS' at 3000 rpm.
Cells were resuspended in 10ml 10% glycerol in H20 and spun down IS' at
3000 rpm. Pellet was resuspended in 0.8ml 10% glycerol in H20 to give 5 x
1010 cells/ml, immediately frozen in liquid nitrogen in 40111aliquots and stored
at -80°.
Luria-Bertani Medium (per liter): 10gr Bacto-Tryptone. 5gr Bact-Yeast Extract,
10gr NaCl.
2.1.2 Transformation of competent cells by eiectroporation
Electroporation was performed to transform competent XLI blu bacterial cells
prepared as described above with plasmidic DNA.
Biorad Gene Pulser apparatus was used.
lOng of DNA in water was added to 40111of competent cells in a pre-cooled
eppendorf tube. After 1 minute in ice, the suspension was transferred to a cold
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electrocuvette (Biorad) and shaken to the bottom. One pulse of 12.5 kVJcm
with a time constant of 4.5 to 5.0 msec was applied. The Gene Pulser apparatus
was set to the 25f.lF capacitor and 2.5 kV, and setting the Pulse controller to 200
Q. One ml of SOC medium was added immediately at room temperature (RT)
and cells gently resuspended. Cells were transferred to a 15ml Falcon tube and
incubated for 1 h at 37° with shaking. Cells were plated on agar plates
containing ampicillin-resistant medium.
SOC medium: LB + 0.4% glucose + 10mM MgS04 + 10mM MgCl2
2.1.3 Dephosphorylation assay
Dephosphorylation of linearized plasmid DNA was performed with alkaline
phosphatase (AP) from calf intestine (Boheringer), an enzyme that removes 5'-
phosphate groups from linear DNA.
Linearized 5' protruding plasmid DNA was incubated 1 h at 37°C in Ix AP
buffer containing 10mM ZnCI2, 10mM MgCI2, 100mM Tris-HCI pH 8.3, and
alkaline phosphatase in the amount of 1 unitl100pmoles of DNA. Linearized 3'
protruding or blunt end plasmid DNA was incubated in the same buffer but
with 1 unitl2pmoles of AP; the reaction was allowed to proceed 30' at 37°C
and, after adding another aliquot of AP, 45' at 55°C.
The reaction was stopped and AP inactivated adding 0.5% SDS, 5mM EDTA,
100f.lg/ml proteinase K (Sigma), and incubating 30' at 56°C. This step was
followed by two rounds of extraction with phenol:chloroform. Aqueous phase
was precipitated with two volumes of EtOH absolute and O.lM NaCI, washed
with EtOH 70% and resuspended in a TE Ix at a concentration of about
100ng/f.l1.
2.1.4 Ligation
The ligation reaction between a linearized dephosphorylated plasmid DNA and
a DNA fragment was performed in 10~1 of total volume, with l x T4 DNA
ligase buffer, and 1 Weiss unit of T4 ligase (Biolabs) per 100ng of plasmid. T4
DNA ligase from Biolabs was used. The reaction was allowed to proceed at
16°C for 16 hrs. Then, the ligation reaction was dialyzed to remove any salt.
O.025f.lm-thick filters from Millipore were used. After dialysis, DNA was ready
to transform bacterial cells.
2.1.5 Plasmid preparation: mini prep
Plasmid DNA was extracted from bacterial culture using the alkaline lysis
method (Molecular Cloning, Second Edition, Sambrook, 1., E.F. Fritsch, T.
Maniatis, CSHL Press, 1989).
A single colony was grown in 1.5ml of LB with ampicillin 100Jlg/ml oln at
37°C with shaking. Bacterial culture was centrifuged in Eppendorf at high
speed. Pellet was resuspended in 100f.l1of a solution containing: 25mM Tris-
HCI pH 8, 10mM EDTA, 150mM Glucose, and stored 5' at room temperature.
200f.l1of a solution containing O.2N NaOH, 1% SDS were added, and stored 5'
in ice. 150JlI of a solution containing 3M KAc were added and stored 5' in ice.
The solution was centrifuged 5' in Eppendorf at high speed, and the supernatant
was extracted with an equal volume of phenol:chloroform. The aqueous phase
was precipitated with 1ml of EtOH absolute, washed with EtOH 70%, and
resuspended in 20f.l1of TE l x.
DNA was ready to be digested with restriction enzyme.
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2.1.6 Midiprep
In order to obtain amounts of DNA up to lOOllg, plasmid midi preparation was
performed using the Qiagen Columns (Promega), starting from 50-100ml
bacterial colture. The following protocol corresponds to the Qiagen procedure,
supplied by the Qiagen kit.
A single colony was grown in 50-100ml of LB plus ampicillin oln at 37°C with
shaking. The culture was centrifuged at 1000 g in Varifuge RF (Heraeus
Sepatech). Pellet was resuspended in buffer Pl. 4ml of buffer P2 was added,
mixed gently and incubated 5' at room temperature. 4ml of buffer P3 was
added, mixed gently and centrifuged 30' at 4°C at a speed> 15,000 g.
Supernatant was removed and applied onto a Qiagen-tip 100 previously
equilibrated with 3ml of buffer QBT. The supernatant was allowed to enter the
resin by gravity flow. The Qiagen-tip 100 was washed with 10ml of buffer QC,
and then DNA was eluted with 5ml of buffer QF. DNA was precipitated with
0.7 volumes of isopropanol, and centrifuged 30' at room temperature at a
speed>15,000 g. DNA was washed with EtOH 70%, and resuspended in a
suitable volume of TE 1x.
2.1.7 Caesium Chloride preparation
This protocol of DNA extraction allows to prepare very large and clean
amounts of plasmid DNA.
A single colony was incubated in 5ml of LB with ampicillin lOOllg/ml 6-8 hrs
at 37°C with shaking. The culture was inoculated in 500ml of LB with
ampicillin lOOllg/ml oln at 37°C with shaking. The first part of the extraction is
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based on the alkaline lysis method previously described (see above), with the
difference of the use of large amount of the solutions and the final resuspension
of DNA in 8ml of TE l x. 8ml of CsCI were added, together with Ethidium
Bromide at a final concentration of 250llg/ml. Polycarbonate tubes (11.5ml of
volume, Kontron Instruments) were used. The samples were put in the quick
seal tubes, and filled with a blank solution made with 8gr CsCI, 8ml TE l x and
Ethidium Bromide 250llg/ml. The tubes were sealed with the appropriate
apparatus. Samples were centrifuged using the ultracentrifuge Centrikon T-
1180 (Kontron Instruments) at a speed of 100,000 g for 16-18 hrs at 20°C.
Plasmid circular DNA was removed by aspiration with a syringe, after
identification with UV-transilluminator. Sample was collected in a new quick
seal tube and centrifuged again at 100,000g for 4 hrs at 20°C. Plasmid DNA
was collected again by a syringe, and extracted several times (4-6) with H20-
saturated butanol. The aqueous phase was dialyzed in TE lx pH 8.0 to remove
all CsCI: o/n at 4°C with a stirrer, followed by 3x3 hrs washes at the same
conditions. DNA was precipitated with EtOH absolute and O.1M NaCI, washed
in EtOH 70%, and resuspended in the suitable volume of TE l x.
2.1.8 Agarose gel Electrophoresis of plasmid DNA (Restriction
enzyme digestion)
Plasmid DNA was loaded on a 0.8-1 % agarose gel prepared in TAE l x.
Electrophoresis was performed at 80V at room temperature, using a sample
buffer containing xylene cyanol 6x. DNA was visualized by UV-
transilluminator. Pictures were taken using the Polaroid MP 4+ (250V,
-600W), and Polaroid film (8.5x10.8 em).
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2.1.9 RNA extraction
RNA extraction was performed according to Chomczynski P., and Sacchi N.,
1987.
Adult mouse diaphragms were homogenized with Dispergerate X 600W (220V,
50Hz, 600W, Heidolph) for 30", using solution D in the ratio of 1mlll00mg of
tissue. Tissue was minced on ice.
Solution D: 4M guanidinium thiocyanate (Fluka), 25mM sodium citrate
(Sigma), 0.5% sarcosyl (Sigma), 0.1M f3-mercaptoethanol (Sigma).
Sequentially, O.lml of 2M sodium acetate pH 7.4 (Sigma), l ml of H20-
saturated phenol (Merck), and 0.2ml of chloroform-isoamyl alcohol mixture
(49:1) were added to the homogenate, with mixing by inversion after the
addition of each component. After cooling 15' on ice, the suspension was
centrifuged at 10,000 for 20' at 4°C. The aqueous phase, containing the RNA,
was transferred to another tube. After the addition of 1ml of isopropanol the
aqueous phase was placed 1 h at -20°C to allow RNA precipitation. After a
centrifugation at 10,000 g for 20' at 4°C RNA pellet was resuspended in 0.3ml
of solution D. The resuspension was transferred into an eppendorf tube and
precipitated again at -20°C after the addition of 1 volume of isopropanol. After
centrifugation in Eppendorf centrifuge for 10' at 4°C, and quick washing with
EtOH 75%, the RNA pellet was resuspended in a suitable volume of sterile
H20. Quantitative estimation of RNA was performed by both loading a small
aliquot of the resuspension on an agarose gel, and by spectrophotometer
analysis. RNA was stored at -20°C.
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2.1.10 eDNA synthesis: RT ·PCR
10llg of mouse diaphragm RNA plus random examers oligonucleotides 151lM
were denatured 2' at 95°C. Then the following components were added: reverse
transcriptase buffer lx, dNTPs ImM (Pharmacia), DTT 5mM (Sigma), and 200
unit of M-MLV Reverse Transcriptase (Gibco BRL). After an annealing
reaction 10' at room temperature, the reaction was allowed to proceed 1 h at
37°C. The neo-synthesized eDNA can be immediately used for an amplification
reaction by PCR (Sill), or can be stored at -20°C.
2.1.11 PCR Analysis
PCR assay was performed using the Polymerase Chain Reaction machine
Protocolt-' thermal cycler (Ams, Biotechnology Ltd). It was used to amplify
DNA fragments from plasmids, or mouse genomic DNA. In both cases, small
amounts of DNA (IO-IOOng) was added to a mix containing: Taq Polymerase
buffer lx, 25mM MgCI2, 0.2mM dNTPs, 50 picomoles 3' primer, 50 picomoles
5' primer, and H20. Then 2 units of Taq Polymerase (Promega) were added.
100111of paraffin oil was used to cover the reaction mixture, and avoid
evaporation during the denaturing step. To amplify fragments of DNA from
plasmids, 5' of denaturation at 95°C preceded 30 cycles at the following
conditions: 30" at 95°C (denaturation); 30" at the annealing temperature chosen
every time depending on the primers used (annealing); 45" at 72°C
(elongation). After 30 cycles, a 5'-long elongation step at 72°C followed.
Samples were stored at -20°C before checking amplified DNA on agarose gel.
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The annealing temperature was calculated using the melting temperature (TM)
of the primers used. The TM was obtained according to this formula:
TM=69.3+0.41 x ((G+C)%)-6501L
where Lelength of the primer. The annealing temperature derives from the
lower TM between the two primers, minus 5°C.
2.1.12 DNA sequencing
2.1.12a Sequencing Reaction.
DNA was sequenced using the T7 Sequencing Kit (Pharmacia), based on the
method of Sanger (Sanger et aI., 1977).
1.5-2.5Ilg plasmidic DNA was denatured 5' at room temperature with NaOH
0.2N in 20111of total volume. Then DNA was precipitated with EtOH absolute
and 0.3M NaAc ,washed with EtOH 70% and resuspended in lOll1 of H20.
Denatured DNA is ready for sequencing reaction. Three different steps can be
distinguished: the annealing reaction, the labelling reaction and the termination
reactions. In the annealing reaction, the following components were added to
the denatured DNA (l01l1): 2111of primer 0.5pmoli/llg, 2111 of reaction buffer
containing 1M Tris-HCI (pH 7.6), 100mM MgCl2 and 160mM DTT, for a final
volume of 141l1. The annealing reaction was allowed to proceed for 5' at 65°C,
and cooled slowly, first 10' at 37°C and then 10' at room temperature. In the
labelling reaction the following components were mixed: the annealed DNA-
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primer (14Jl,l), 1Jl,1of DTT O.1M, 3Jl,1of labelling mix containing 1.37511Meach
dCTP, dGTP, dTTP and 333.5 mM NaCl, IJl,1of [a-35S]-dATP (10 mCi/ml,
>1000 Ci/mmol), 2111of T7 DNA polymerase diluted using the Enzyme
Dilution Buffer in a ratio 1:4. Enzyme Dilution Buffer contains: 20mM Tris-
HCl pH 7.5, 5mMDTT, 100Jl,g/ml BSA, 5% glycerol. The labelling reaction
was allowed to proceed for 5' at room temperature, followed by the termination
step. The termination is based on the presence of a dideoxinuc1eotide, that
prevents the further elongation of DNA synthesis. Four different termination
mix are used one for each nucleotide, named A Mix, C Mix, G Mix and T Mix.
Each mix contains the corresponding dideoxinucleotide. For example, this is
the composition of the A Mix: 840JlM each DCTP, dGTP, dTTP; 93.5JlM
dATP; 14JlM ddATP; 40mM Tris-HCl (pH 7.6) and 50mM NaCl. The Short-
Mix were used. During the 5' incubation time, 2.5JlI of each termination mix
were aliquoted in different wells of a microtiter plate. 4.5JlI of labelling reaction
was transferred into each of the four pre-warmed wells, containing the
termination solutions, mixed gently, and incubated 5' at 37°C. 5JlI of Stop
Solution was added to each well. Stop Solution contains 0.3% each
Bromophenol Blue and Xylene Cyanol, 10mM EDTA pH 7.5, 97.5% deionized
formamide. The samples were ready to be loaded on a polyacrylamide gel.
2.1.12h Electrophoresis
Samples were loaded on a polyacrylamide gel containing 6% acrylamide, 1x
TBE, 8M Urea. 6% acrylamide was a mix of acrylamide (DNA-sequencing
grade, BioRad) and N,N'-methylenebisacrylamide, in a ratio 30: 1.
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The solution must be filtered using a 0.45Jlm filter (Nalgene), degassed, and
stored at 4°C. A 4mm-thick gel was used. To allow polyacrylamide
polymerization 0.08% APS (Sigma), and 0.05% Temed (BioRad) were added
Electrophoresis run was performed at 1500V for I h and half (short run), or 4
hrs (long run). Gel was detached from the glasses, transferred to a Whatman
3MM paper and dried by Dryer from Biorad for 1 h at 80°C. Then it was
exposed to Hyperfilmt'<-Ml" (Amersham) for 12-24 hrs and then developed
using the automatic developer machine.
2.1.13 Elution of DNA bands from agarose gels
DNA bands from digested plasmidic DNA were eluted from agarose gel using
the Low-Melting Agarose (Sigma).
Digested DNA was loaded on a 0.7% LM-agarose gel in TAE l x,
Electrophoresis run was performed at 4°C (cold room). The specific fragment
of DNA was cut from the gel after identification at UV-transilluminator. An
equal volume of phenol pH 8.0 was added and put at 65°C for 5-10', until the
agarose was completely resuspended. After shaking the mixture was put ice for
15' and then centrifuged at highest speed in Eppendorf centrifuge (14000 rpm).
The upper phase was collected and precipitated adding 2 volumes of EtOH
absolute and O.lM NaCl. After precipitation and washing with EtOH 70%, the
pellet was resuspended in a small volume of TE 1x.
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2.1.14 Genomic DNA extraction from mouse tails
A small piece of tail was cut from a two-week old mouse. It was placed in
750/.11of buffer containing 50mM Tris-HCl pH 8, 100mM EDTA, 100mM
NaCI, 1% SDS, 0.5 mglml Proteinase K, and incubated oln at 55°C. After
cooling at room temperature for 15', it was shaken for 5' and 250111of saturated
NaCI was added (6M NaCI). It was shaken again 5' and spun 10' at full speed in
Eppendorf centrifuge. 750/.11were taken from the top phase, transferred to a
new tube and 500/.11of isopropanol were added. After shaking for 2', it was
spun 5' at full speed in Eppendorf centrifuge. The pellet was washed with EtOH
70% and allowed to air dry. The pellet was resuspended adding 200/.11TE Ix
and incubating at 37°C for 2h, with occasionally shaking.
Genomic DNA was stored at 4°C.
This procedure yields 50-IOOllg of genomic DNA.
2.1.15 Restriction enzyme digestion of plasmid DNA and mouse
genomic DNA.
Plasmid DNA was digested with the appropriate restriction enzyme In a
concentration of 1 Unit/Jug. in 20111of total volume containing the restriction
enzyme buffer 1x. The reaction was allowed to proceed 2-3 hrs at the
temperature suitable for the restriction enzyme used. Most of the digestions
were performed at 37°C. The digestion was checked by loading an aliquot of
the restriction (1/10) on agarose gel, and visualizing DNA bands at the UV-
transilluminator.
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Mouse genomic DNA was digested with the appropriate restriction enzyme in a
concentration of 1 Unit/lug, in 60~1 of total volume containing the restriction
enzyme buffer Ix. The digestion was allowed to proceed for 16 hrs at 37°C.
Digested DNA was loaded on an agarose gel for Southern analysis as described
(see below).
2.1.16 Southern blot assay
Genomic DNA digested with the appropriate restriction enzyme was loaded on
an agarose gel 0.8% in TAE 1x, using a sample buffer containing xylene cyanol
6x. After electrophoresis, the gel was placed in 0.25M HCI for 15'. The gel was
rinsed in H20 and placed in denaturing solution: NaOH O.5M, 1.5M NaCl.
After 30' with shaking, the gel was rinsed again with H20 and placed in
neutralizing solution: NaCI 1.5M, 0.5M Tris-HCI pH 7.2, O.OOlMEDTA. After
10' with shaking, the capillary blot is set up: a tray was filled with 20x SSC
(blotting buffer), a platform was made and covered with a sheet of Whatman
3MM filter paper saturated with blotting buffer and in direct contact with the
blotting buffer in the tray. The gel was placed on the wick and surrounded with
parafilm to prevent the blotting buffer being adsorbed directly into the paper
towels above (see below). A sheet of Hybond-N membrane (Amersham) is cut
to the exact size of the gel, and placed on top of the gel. Three sheets of 3MM
paper, wetted with blotting buffer, were placed on top of Hybond-N membrane.
A column of adsorbent paper towels was placed over the three 3MM wetted
sheets, and a 0.75-lKg weight was placed on the top. The transfer was allowed
to proceed for l6h.
60
After blotting, the apparatus was disassembled. Before removing the gel the
membrane was marked with pencil to allow later identification of wells. The
membrane was washed with 2x SSC and allowed to air dry.
DNA was fixed on the membrane using UV-crosslinker apparatus UV-
Stratalinker™ 2400 (Stratagene). The membrane was wrapped in SararrWrapO'
placed DNA-side up in the crosslinker for I'.
After fixing, the membrane was ready to be hybridized.
SSC 20X (per liter): NaCl 175.3 gr, sodium citrate 88.2 gr, pH 7
2.1.17 Random primed reaction
A specific fragment of DNA eluted from an agarose gel was radiolabeled using
the "High Prime" kit from Boheringer Mannheim, based on the random primed
DNA-labelling method. 25-501lg of DNA were denatured at 95°C for 5', and
added to 4111of reaction mixture from High Prime kit. The reaction mixture
contains all the components necessary for a random primed reaction: Klenow
enzyme and its buffer, deoxyribonuc1eotides, random hexanuc1eotides as
primers. 5J.11of [a-32P]-dCTP (10 mCilml, 3000 Ci/mmol) were added to a
final volume of 20J.11.
The reaction was allowed to proceed for 30', and then stopped by adding 1mM
EDTA. The radiolabeled DNA fragment was separated from non-incorporated
deoxynucleotides by passing the reaction mixture in a packed Sepharose G-50
column. The column was made as follows. Sephadex G-50 resin was suspended
in TEN buffer: 10mM Tris-HCI pH 7.5, ImM EDTA pH 8, IOOmMNaCI, 0.1%
SDS. The equilibrated resin was packed over a small amount (2001ll) of glass
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beads (Sigma,425-600 microns, acid-washed)~ equilibrated in TEN buffer, and
packed in a holed eppendorf tube. The column was put in a 15ml Falcon tube.
The volume of the random primed reaction mixture was brought to I00~1,
loaded on the column, and spun 5' at 1000 rpm. The eluate was collected at the
bottom of the Falcon tube. 1ul of the eluate was counted at the ~-counter
machine in order to know the amount of incorporated radioactivity.
Before using, the radiolabeled DNA was denatured 5' at 95°C.
2.1.18 Hybridization
The hybridization of a membrane was performed using tubes in a heater with
roller. The Hybond-N membrane with UV-crosslinked DNA was pre-
hybridized at 65°C in Church buffer: 0.5% Na2HP04 (H20)2 pH 7.2, 7% SOS,
ImM EOTA, 1% BSA. After 30' of pre-hybridization, the membrane was
hybridized in 5-10ml of Church buffer adding the radioactive probe prepared as
described (see above). The probe was added at a concentration of 5xl0
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cpm/ml. The hybridization was allowed to proceed for 16 hrs at 65°C. Then the
membrane was washed 2x20' at 65°C using the following wash buffer: 40mM
Na2HP04 (H20)2 pH 7.2,1 % SOS. After washing the membrane was wrapped
in SaranWrapTM and exposed o/n with Hyperfilm™-MP (Amersham) in an
autoradiography cassette at -80°C. The film was then developed using the
automatic developing machine.
Church buffer: Na
2
HP04 0.5 M, SOS 1%, EDTA ImM
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2.2 Transgenic mouse techniques
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Materials
All reagents utilized are from Gibco BRL, unless otherwise indicated.
~-mercaptoethanol: ~-mercaptoethanol 14.3mM (Sigma) was dissolved in PBS
Ix at a final concentration of 10mM. The solution was filtered with a 0.22Jlm
filter (Millipore), and stored at +4°C.
LIF: Leukaemia Inhibitory Factor was dissolved in 10ml of ES cell medium at a
final concentration of 105U/ml, filtered with a 0.22Jlm filter (Millipore), and
stored at 4°C.
Gelatin: 1%(w/v) tissue culture grade gelatin (Sigma) was mixed in H20 and
sterilized by autoclaving. The working solution is 0.1% and is made by diluting
the stock solution in sterile H20.
Mytomicin D: mytomicin D (Sigma) was dissolved in PBS Ix at a
concentration of 2mg/ml, and stored at -20°C. Stocks for use were made
diluting 0.25ml into 50ml of MEF, and storing at -20°C.
G-418: G-418 sulphate (Geneticin") was dissolved in HEPES O.lM pH 7.4 at a
concentration of 50mg/ml, filtered with 0.2Jlm filters, and stored at 4°C.
PBS lx: phosphate-buffered saline. For I liter the following component were
mixed: 8g NaCI, 0.2g KCI, 0.2g KH2P04, 1.072g Na2HP04.7H20 in water. pH
was adjusted to 7.2 using a saturated solution of Na2HP04.7H20. It was filter
sterilized and stored at room temperature.
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DMEM: Dulbecco's modified Eagle's medium.
2.2.1 Culture of feeder layers and mytomicin D treatment.
Feeder layers are primary embryo fibroblasts. They were prepared from 13.5
day post-coitum (d.p.c.) neo-resistant mice, aliquoted on freezing vials and
stored in liquid nitrogen.
Feeder layers were grown in MEF (mouse embryonic fibroblasts) medium:
DMEM + 4.5flgll glucose, 10% foetal calf serum (FCS) heat-inactivated (56°C
for 30'), glutamine 2mM, penicillin/streptomycin 100flgiml.
A vial of fibroblasts was thawed quickly in a bath at 37°C. Fibroblasts were put
in a 15ml falcon containing 6ml of MEF medium, and centrifuged 3' at
1000rpm. Pellet was resuspended in 10 ml of MEF medium and plated on a 10-
em diameter plate. Feeder layers were allowed to grow and expand before
treatment with mytomicin D. Fibroblasts were treated with mytomicin D before
being used as substrate to plate Embryonic Stem (ES) cells. MEF medium was
sucked off, and MEF + mytomicin D LOug/ml was added, in a volume suitable
to cover the plate. After 3 hrs at 37°C, 5% C02, the medium was removed and
cells were washed with PBS l x. Cells were trypsinized a few minutes at room
temperature, and then MEF medium was added. Fibroblasts were centrifuged at
15°C for 3' at 1000rpm in a Minifuge T (Hearaeus Sepatech). Cells were
resuspended in the suitable volume of ES cell medium, and plated to be used as
feeder layers for ES cells.
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2.2.2 ES cell culture
ES cells were grown In the following culture medium: DMEM + 4.Sllg/l
glucose, IS% PCS heat-inactivated (S6°C for 30'), glutamine 2mM,
penicillin/streptomycin IOOllg/ml, ~-mercaptoethanol 100 11M, Leukaemia
Inhibitory Factor (LIF) 103 u/ml. This medium is suitable for El4 ES cells. ES
cells Rl require, in addition, Na-pyruvate ImM, and NEAA (Non Essential
Amino Acid, Seromed) 1% of stock solution. ES cells were grown on feeder
layers, that is fibroblasts from neo-resistant mice, treated with mytomicin D as
described.
A vial of ES cells previously frozen was thawed quickly in a bath at 37°C. ES
cells were put in a ISml falcon tube containing 6ml of ES cell medium, and
centrifuged 3' at 1000rpm. Pellet was resuspended in Sml of medium and plated
on a 6-cm diameter plate with feeder layers. Medium was changed daily. ES
cells were allowed to grow until they reached the suitable amount to be used in
a round of electroporation of plasmid DNA.
2.2.3 Electroporation of plasmid DNA into ES cells
Es cells, grown as described (see above), were washed with PBS Ix l' at room
temperature; after trypsinization S' at room temperature, cells were collected,
diluted in Sml of ES medium and centrifuged 3' at 3000rpm. Cells were
resuspended in ES medium and plated 30' at 37°C in a plate without feeder
layer. This pre-plating step allows the elimination of fibroblasts that attach to
the plate. Cells were collected and centrifuged again l' at 3000rpm. Cells were
resuspended in ml PBS Ix and counted using the appropriate counting glass. In
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order to get a concentration of Ix 107 cells/ml, cells were centrifuged again and
resuspended in the suitable volume of PBS Ix. Biorad Gene Pulser apparatus
was used. 0.9ml of cells were added to a cuvette, followed by addition of DNA.
IOug, 25f,lg or 50f,lg of linearized plasmid DNA was used, in a volume not
greater than 50f,l1.Electroporation was performed in the following conditions:
240V,500f,lF.
After electroporation cells were stored 5' at room temperature, and then were
plated, distributing the 0.9ml into 8-cm diameter plates.
24 hrs after electroporation, the medium was changed.
2.2.4 Selection with G-418 and gancyclovir
48 hours after electroporation G-418 selection started. G-418 was used at a
concentration ranging from 0.325mg/ml to O.350mg/ml, depending on the ES
cells used. Medium was replaced every day with fresh medium. 6 days after the
beginning of G-418 selection, gancyclovir selection started, and proceeded
together with G-418 selection. 500mg of powder gancyclovir (Cytovene,
Sintex) were dissolved in 10mi PBS lx, to a final concentration of 196mM. It
was diluted in ES medium (containing also G-418) in the following
concentration: 1f,l1l98f.l1ES medium, to get a final concentration of 2mM. 10ml
of gancyclovir 2mM in ES medium were prepared, filtered with O.21lm filters,
and stored at 4°C. Gancyclovir for the selection was used at a concentration of
21lM, so diluting III 000 the 2mM stock. Gancyclovir selection was allowed to
proceed for two days. On the second days, colonies resistant to both G-418 and
gancyclovir were started to be picked up. The plate containing the colonies was
washed with PBS l x. PBS l x was added to cover the plate. The plate was
placed on an inverted microscope, and individual colonies were picked up by a
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mouth-controlled pipette. Once picked up, the resistant colony was allowed to
grown in a well of a 96-well plate according to Ramirez-Solis et al. 1993. ES
cells were grown on feeder layers treated with mytomicin D as described .
150J..lIof ES cell medium per well was used. Cells were allowed to grow at
370C, 5% C02 for 3-5 days. Medium was changed if necessary (when it started
turning yellow). When approaching confluence, cells in the wells were washed
with PBS 1x, and 50J..lI of trypsin per well were added and sucked off
immediately. After 1', the remaining trypsin was removed. 150111of ES cell
medium was added, followed by gently pipetting. 75111of resuspended cells
were transferred to a gelatinized 96-well plate (0.1% gelatin), where they were
grown to extract DNA. The other 75J..lIremained in the wells of the original 96-
well plate. where they were allowed to grow for 2-4 days before being frozen.
To allow the growing, some ES cell medium (75111)was added to the wells of
both the gelatinized plate and the original one.
2.2.5 DNA extraction from ES cells in 96-well plates
Cells on the gelatine -coated plates were allowed to grow until they turned the
medium yellow every day (4-5 days). Wells were rinsed twice with PBS l x.
50J..lIof lysis buffer per well were added. The plate was incubated oln at 60°C in
humid atmosphere. The next day, 100J..lIper well of a mix of NaCI and EtOH
were added. The mix was prepared adding l50J..llof 5M NaCI to 10mi of EtOH
absolute. After 30' at room temperature nucleic acids precipitate as a
filamentous network. The solution was discarded inverting the 96-well plate.
Nucleic acids were rinsed three times with EtOH 70%. After drying, DNA was
ready to be digested with restriction enzymes.
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2.2.6 Digestion with restriction enzyme of DNA on 96-well plates.
The restriction digestion mix was prepared as follows: l x restriction buffer,
ImM spermidine, IOOllg/ml bovine serum albumin (BSA), 100llglml RNase A
and 10 units of the chosen restriction enzyme per sample. 30lll per well of
restriction digest mix were added, and the reaction was incubated oln at 37°C in
humid atmosphere. The next day, digested DNA was ready for conventional
electrophoresis and Southern analysis (as described in section 1).
2.2.7 Freezing of selected clones
The freezing of selected clones in 96-well plates was performed according to
Ramirez-Solis et al., 1993.
Medium was changed 4 hrs before freezing. Medium was discarded by
aspiration and cells were rinsed twice with PBS 1x. 50111of trypsin per well
were added using the multichannel pipettor, followed by incubation of the 96-
well plate for 10' at 37°C, 5% C02. 50lll of 2x freezing medium per well were
added, and cells were dissociated gently pipetting up and down. 100111of sterile
light paraffin oil per well were added to prevent degassing and evaporation
during storage at -70°C. The 96-well plate was sealed by Parafilm, and stored at
-70°C.
Freezing medium 2x: 60% DMEM, 20% FCS, 20% DMSO (Sigma).
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2.2.8 Thawing of selected clones
The 96-well plate was taken out of the freezer and placed for 10'-15' at 37°C,
5% C02. Once identified the selected clones, the entire content of the well was
put into a well of a 24-well plate containing 2ml of medium. The medium was
changed the next day to remove the DMSO and the oil.
2.2.9 Blastocyst recovery
Blastocysts were recovered by C57 mouse strain. The pregnant C57 mouse was
killed on the fourth day of pregnancy (3.5 d.p.c.) by cervical dislocation. At this
time blastocysts are present in the uterine lumen, and were recovered by
removal and flushing of the uterine horns with the appropriate culture medium
(see below). A cut through the utero-tubal junction on each side was made,
freeing the entire tract. The tract was spread out in a dry sterile Petri dish and
any remaining mesentery and fat was trimmed away. A cut across the cervix
was performed to expose the entrance to both uterine horns. Inserting a Pasteur
pipette tip into the cervical end 0.5ml of medium was flushed through each
hom. Medium, together with blastocysts, flowed freely through the tract.
PB-l medium + 10% heat-inactivated foetal calf serum (56°C for 30').
PB-I solution was prepared as follows:
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Stock solution (gIlOOml)Volume (ml)
NaCI 0.9 68.96
KCI 1.148 1.84
Na2HP04.12H20 5.5101 5.44
KH2P04 2.096 0.96
CaC12.2H20 1.1617 0.88
MgCl2 3.131 0.32
Na pyruvate 0.020 22.40
The following were added to make up 104ml of medium:
penicillin
glucose
H20
6.2mg
104mg
2.16ml
phenol red (l%) O.lml
Foetal calf serum at a final concentration of 10% was added. Complete medium
was filter sterilized, and refrigerated until use.
2.2.10 Injection of selected clone into mouse blastocyst
The ES cell clone selected to be injected was grown in ES medium in a plate
with feeder layers as described, until they reach the exponential phase of
growing. The day of injection ES cells were fed. One hour later they were
washed with PBS lx, and trypsinized l' at room temperature. After dilution
with ES medium, trypsinized cells were centrifuged 3' at 1000rpm. They were
resuspended in ES medium and plated 30' at 37°C on a plate without feeder
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layers. The pre-plating step allowed the removal of feeder layer cells. Cells
were collected and centrifuged again 3' at 1000rpm. Pellet was resuspended in
50JlI of ES cell medium and stored at 4°C. 13-15 ES cells were injected into
mouse blastocysts previously withdrawn (see above). Injection was performed
using mechanical force micromanipulators and a standard microscope, and a
micromanipulator chamber in which the embryo and the ES cells were kept in
hanging drops. Microinstruments for use in blastocyst injection are fashioned
out of glass capillary fitting the instrument holders (for example, Drummond
custom capillary, 1mm outside diameter, 0.75 inside diameter). Only two
instruments are necessary, a holding pipette to hold and stabilize the blastocyst,
and a cell injection pipette to pick up and inject the ES cells. Both pipettes were
made by a pipette puller. For the injecting pipette, a bevelled-tip pipette is
preferred. In this case, after pipette puller treatment, the pipette is placed under
a dissecting microscope and a scalpel blade is used to brake off the tip.
Blastocyst and a cell suspension of ES cells were introduced into drops in the
manipulation chamber using a mouth-controlled Pasteur pipette. This can be
done under a dissecting microscope. The injection instruments can be set-up in
the micromanipulator, and filled with oil by positive pressure. The tips of the
two pipettes were put in the same focus field. The manipulation chamber was
introduced. 12-15 ES cells were picked up at the tip of the injecting pipette
using suction. A blastocyst was picked up with the holding pipette by suction,
positioning it so that the ICM (inner cell mass) could be seen in profile against
the pipette. The injected pipette was allowed to penetrate the trophoectoderm
layer, the ES cells were expelled into the blastocoelic cavity, and the pipette
was removed. When all the available blastocysts had been injected, they were
transferred to culture medium for a brief period of culture before being
transferred to pseudo-pregnant hosts.
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2.2.11 Transferring of injected blastocyst into foster CDI mother
COl female mice (white-colored) were rendered pseudo-pregnant by mating
with sterile males during oestrus, because they displayed the hormonal profile
of a pregnant female when the stimulus of mating occurs during oestrus. Sterile
males were produced by vasectomy, that is the cut of vas deferens. In general
embryos can be transferred to a synchronous host, but, since in vitro
manipulation of embryo cause a delaying embryonic development, the more
efficient method is to transfer embryos to host that are one day asynchronous.
Thus, fourth day blastocysts were transferred to the uterus of females in the
third day of pseudo-pregnancy. 4-5 injected blastocysts were transferred in each
horn of the pseudo-pregnant female. An embryo transfer pipette was used. It
was made like the holding pipette, but the overall diameter at the tip was larger
so that the opening could easily accomodate embryos (110-130~m). After a
skin incision performed on the dorsal side of the female, a needle was inserted
through the muscle layer of the uterus, about 2mm from the utero-tubal
junction. After removing the needle without taking the eyes off the hole, the tip
of the transferred pipette was inserted into the hole, and embryos were expelled
into the lumen together with air bubbles that served as indicators of embryo
expulsion. Skin incisions were closed by small wound clip.
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2.3. Biochemical techniques
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2.3.1 Microsomal membrane preparation from mouse tissues
Mouse tissues were homogenized with Dispergerate X 600W (220Y, 50Hz,
600W, Heidolph) at setting, followed by dounce homogeniser using 5ml/gr of a
solution containing 320mM sucrose, 5mM Hepes-NaOH pH 7.4 and O.lmM
PMSF (homogenizing buffer). The homogenate was centrifuged at 10,000 g for
5' at 4°. Supernatant was centrifuged at 100,000 g for I h at 4°. Pellet was
resuspended in the homogenizing buffer using a 2ml dounce. Aliquots of
microsomes were immediately frozen in liquid nitrogen and stored at -80°.
Protein concentration of the microsomal fraction was quantified using a protein
assay kit (Bio Rad).
2.3.2 Western blot assay of mouse tissue microsomal membranes
A 1.5 mrn gel was prepared, with 5% acrylamide in the resolving gel and 4% in
the stacking gel. Microsomal membranes were loaded after adding Laemmli
buffer (Ix final) and denaturing at 95°C for 2'. Laemmli buffer: 0.0025M Tris-
HCI pH 6.8, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.00 1%
bromophenol blue (Laemmli, U.K., 1970). Electrophoresis was allowed to
proceed for 16 hrs at 60 Y at 4°C (cold room), in the following running buffer:
25mM Tris, 192rnM glycine, 0.1% SDS, pH 8.3. Then electro-blot was
performed at 400 rnA at 4°C for 6 hrs, using nitrocellulose membrane Protran
BA 85 (Scheicher & Schuell) and electro-blotting apparatus (Hoefer scientific
instruments), in blotting buffer: 25mM Tris, 192mM glycine, 0.01% SDS, 10%
methanol, pH 8.3. After blotting, the membrane was blocked 3 hrs at room
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temperature in blocking buffer: 50mM Tris-HCI pH 7.4, ISOmM NaCI, 0.2%
Tween 20, 5% dry milk. The membrane was incubated with the primary
antibody oln at room temperature in blocking buffer. All the antibodies used
were diluted 1:3000 (Giannini et al., 1995). The membrane was washed 4x 15'
in wash buffer: 50mM Tris-HCI pH 7.4, 150mM NaCI, 0.2% Tween 20, 0.5%
dry milk, followed by incubation with the biotin-conjugated anti-rabbit
secondary antibody. The biotin is conjugated to the alkaline phosphatase. The
secondary antibody incubation was performed in wash buffer without tween.
The membrane was washed 4x15' in wash buffer, and then it was incubated
with streptavidin-biotin complex (Amplified Alkaline Phosphatase Immunoblot
reagents from Biorad). The membrane was washed again 4xlS' before
development. The two substrates bromochloroindolyl phosphate (BCIP) and
nitro blue tetrazolium (NBT) are added to the alkaline phosphatase buffer:
100mM NaCI, 5mM MgCI2, 100mM Tris-HCI pH 9.S. 33fll of S% NBT in 70%
dimethylformamide, and 66fll of 5% BCIP in H20 were added to 10ml of
alkaline buffer. 10ml of alkaline buffer are suitable for lSx15 cm2 membrane.
The blot was developed for 10' at room temperature with shaking, and the
colorimetric reaction was blocked rinsing the membrane with H20.
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2.3.3 Binding analysis with radioactive ligand
2.3.3a Saturation curve and Scatchard analysis
50Jlg microsomal membranes from mouse tissues were incubated for I h at
370C with the following concentrations of [3H]ryanodine (Dupont, O.1IlCillll,
specific activity: 68 Ci/mmol): 0.5nM, InM, 1.5nM, 2.5nM, 5nM, 7.5nM,
10nM, 15nM, 20nM, 25nM, 30nM. The reaction was performed in 200111of
binding buffer containing 1M KCI, 20mM Hepes-NaOH pH 7.4, 100llM CaCl2
and a mixture of protease inhibitors: 76.8nM aprotinin (Sigma), O.83mM
benzamidine (Sigma), ImM iodoacetamide (Sigma), 1.1llM leupeptin (Sigma),
0.7J.1Mpepstatin (Sigma) and O.lmM PMSF (Sigma). The bound [3H]ryanodine
was separated from free ligand by filtering through Whatman GB/F glass fiber
microfilters. The filters were washed with 3x5ml of ice-cold binding buffer, and
2x5ml EtOH 10%. Radioactivity remaining with the filters was measured by
liquid scintillation counting, using ~-counter machine.
Specific binding was calculated as the difference of total and nonspecific
binding measured in parallel assays in the presence of lOIlM unlabeled
ryanodine (Calbiochem). Experiments were performed in duplicate.
Scatchard analysis was performed using the computer program MacLigand.
2.3.3b Ca2+ -dependence Curve
Ca2+-dependence experiments were performed using 10nM [3H]ryanodine in
the following binding buffer: O.3M KCI, 20mM Hepes-NaOH pH 7.4, the
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mixture of protease inhibitors as described above and different concentration of
Ca2+: lOnM, lOOnM, IJlM, lOJlM, lOOJlM, ImM, lOmM, 100mM.
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2.4. Contracture analysis
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Diaphragm strips including the insertion on the rib and on the central tendon
were dissected and mounted between a force transducer (AE 801 Sensonor
Horten, Norway) and a movable hook in a perfusion bath containing
bicarbonate Krebs solution (volume 2ml). The solution was bubbled with 02-
C02 mixture and the temperature was kept constant at 22°C. The preparations
were stretched just above slack length (resting tension -5% of twitch tension)
and supramaximally activated with field stimulation. The output of the tension
transducer was stored in a PC after AID conversion and recalled for analysis.
CEA 1401 AID converter and CEA Spike2 software were used. After
stabilization at 0.1 Hz, twitch and tetani (0.5 s duration) at frequencies of 5, 10,
20 and 50 Hz were recorded.
The depressing effect of external Ca2+ removal was studied on twitches
produced at the rate of 0.1 Hz.
After the electrical responses, the response to pharmacological agents able to
release Ca2+ was tested. For pharmacological agents, increasing doses of
caffeine (range 10-30mM) or 10JlM of ryanodine were used. Each contracture
was followed by washing with Krebs solution without caffeine or ryanodine to
produce a complete relaxation of the preparation.
To analyze the ability of the myofibrils to develop tension in response to direct
Ca2+ activation, the following procedure was used. The preparation was
immersed for 1 h in skinning solution containing EGTA and Triton X-IOO at
low temperature (10°C). Membranes were removed with this treatment. The
solution in the chamber was then replaced with a relaxing solution at pCa 8.
After a few minutes the preparation was activated to develop tension by filling
the chamber with activating solution (pCa 4.5). When tension reached a stable
level, the preparation was relaxed by filling the chamber with relaxing solution.
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The composition of skinning, relaxing and activating solution were previously
described (Bottinelli et aI., 1994).
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Chapter 3
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3.1. The construction of the targeting vector Cl
84
3.1.1 Introduction
The 3' region of the murine RyR3 gene was previously cloned from a 129/Sv
mouse strain genomic library by G. Giannini and A. Nori.
The region is represented in Fig.l.IA. The region used for the construct spans
from the HindIII site upstream the exon B to the EcoRI site just upstream of the
exon G and the 3' UTR (Fig. 1.IB). This genomic region was cloned in two
plasmids using pBluescript (Stratagene, Fig. 1.2) by G. Giannini and A. Nori:
- pBS HIH 1.6: 1.6 kb containing the region from the HindIII site upstream and
the HindIII site just downstream exon B, cloned in the HindIII site of plasmid
Bluescript KS (Fig.1.4A).
- p- l.3: 5.2 Kb containing the region from the HindIII site downstream the
exon B and the EcoRI site upstream the exon H and the 3' UTR, cloned in the
HindIII and the EcoRI sites of pBluescript (Fig. l.4B).
These two plasmids were modified to make a suitable construct useful to
knockout the murine RyR3 gene.
85
A,,
,,,,,,
-(
Z
Q
~oz
l5
u
~
BHind III Hind III Eeo RI 3'
5'
/
/
/
/
/
/
/
/ ex on B
/
Eeo RI
Hind III Hind III
+
Hind III Hind III
Hind III
Eeo RI
pBS WH 1.6
p~ 1.3
Figure lolA and B. A)The 3' region of the murine RyR3 gene. The exons, some
restriction enzyme sites and the 3' UTR region are indicated. B) The region used
for the construct is indicated: the 1.6 Kb HindIIIIHindIII region containing the
exon B was cloned in pBluescript to originate pBSHIH 1.6; the 5.2 Kb
HindIIIlEcoRI region was cloned in pBluescript to originate p~1.3.
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pBluescripl II KS+/-
phagemid
2.96kb
BssH II
T7 i-
SIcl
BslXl
Sac II
fag 1
Noll
Xbal
SpII
BamHl
Smal
Pst 1
EcoR I
EcoRY
Hind III
Bsp1061 (Cia I)
Sail/Him IIIA,,1
Xhol
E:001 091 (On II
Apal
Xpnl
T3 t
BssH II
Figure 1.2. Plasmid pBluescript KS +/- (Stratagene).
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f1 26
31
xr,o I 37
E::oR I 43
pGEM' -7Zf(+) KDn I 53
plasmid Sn:al 56
(3000 bp) C5;)45 I 61
Cia I 67
H!r,a III 72
Ba:":1H I 78
Sa: I 91
ss.x I 100
NSi I 109
+SP6
123
Figure 1.3 Plasmid pGEM 7Zf( +) (Promega).
88
AHindIII exon B HindIII pBluescript
pBS HIH 1.6
B
HindIII EcoRI- r----------------------------~ -
pBluescript
p~ 1.3
Figure 1.4 A and B. The genomic region used for the construct was cloned
in two plasmids, pBS HIH 1.6 (A) and p~ 1.3 (B).
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3.1.2 Strategy
The targeting vector to be transfected into murine ES cells was designed in
order to obtain a high recombination frequency with the chromosomal locus,
and to increase the chance of, and maximize the selection for, clones with a
targeted integration event and against clones with random insertion events. For
the first point, the length of the homologous sequences in the vector was chosen
between 5 and 10 Kb. Concerning the second point, the positive-negative
selection technique (PNS) was used as enrichment strategy for gene targeting
events (Mansour et al., 1988). In this scheme, in addition to the positive
selection permitting the isolation of all the clones which stably incorporate the
plasmid DNA, the vector contains a negative selectable gene at one end: in a
targeted gene replacement event this gene is lost and degraded, whereas clones
in which the vector has been randomly integrated incorporate it. Negative
selection works by killing clones of cells expressing the negatively selectable
gene, i.e. the clones of cells which have integrated the vector at a random
location and clones which have integrated all of the vector components into the
target locus by homologous recombination. The enrichment achieved with
negative selection is highly variable, ranging between 2 and 20-fold.
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3.1.3 The DNA plasmid PCR-neo
The PCR-neo plasmid was built by using the PGK-neo plasmid on one side,
and the pBS HlH 1.6 on the other side.
3.1.3a PGK-neo plasmid
The PGK-neo plasmid (Fig. l.5) was made by cloning in pGEM-7Z(f)+
(Promega, Fig. 1.3) the 1745 bp EcoRI-HindIII fragment from pKJI containing
the PGK-neo cassette (Tybulewicz et aI., 1991), to get a 4.7 Kb plasmid. The
PGK -neo cassette has all the components necessary for the autonomal
expression of the neo gene, that is a promoter, the neo coding region, and a
polyadenylation site. It was built as follows (Tybulewicz et aI., 1991): a 511 bp
C fragment from the mouse PGK-l promoter (Adra et aI., 1987), the coding
portion of the neo gene as a 823 bp fragment from pMClneo (Thomas and
Capecchi, 1987), and 404 bp fragment containing the mouse PGK-I poly(A)
addition site (Adra et aI., 1987).
lOllg of PGK-neo plasmid were cut with the restriction enzymes ApaI for 3 hrs
at 37°C. The linearized plasmid was loaded on an agarose gel in TAE Ix, 0.8%,
and eluted by low-melting agarose method. Then the plasmid was cut with XbaI
for 3 hrs at 37°C; this step was followed by plasmid dephosphorylation. After
AP inactivation, followed by precipitation with EtOH absolute and NaCI O.IM
and washing with EtOH 70%, the digested and dephosphorylated plasmid was
resuspended in 10111of TE l x. 1110 of the resuspension was loaded on an
agarose gel in order to have a quantitative estimation of the linearized plasmid.
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pBS H/H 1.6 Kb PGK-neo
1.6 kb
exon B
pBluescript Apal Xbal pGEM 7Zf( +]ttl neo cassette 1.7 Kb ~ - - _
Apal/Notl----. Xbal._
primer a primer b
amplification by PCR digestion by ApaI and XbaI
1.2 k amplified fragment dephosphorilation
digestion by ApaI and XbaI
ligation
1.2 amplified fragment
pGEM 7Zf(+)
1/4"
primer PR2
1/4"
primer pUC M 13 reverse
PCR-neo
Figure 1.5. Cloning strategy to get the plasmid PCR-neo
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3.1.3b pBS HIH 1.6 plasmid
The pBS HIH 1.6 plasmid was used to amplify a 1.2 Kb band from the 1.6 Kb
genomic fragment. The two oligonucleotides designed for the amplification are
named primer a and primer b. The two primers are localized as shown in Fig
1.5. The first 5' nucleotide of primer a maps at nucleotide 164 of the 1.6 Kb
fragment. The first 5' nucleotide of primer b maps at nucleotide 17 upstream the
3' end of the exon B (nucleotide 1373 from the 5' of the 1.6 Kb fragment). The
1.2 Kb fragment will contain only a portion of the exon B.
These are the sequences of the two primers utilized:
5' ApaIINotI 3'
pnmer a: TAGGGCCCGCGGCCGCCCTCCTGCT AAAGCACCTCTT AT
5' XbaI 3'
primer b: GGTCT AGAA TATCCGGCTCA TCGTCA TC
The ApaI and XbaI sites are underlined, the NotI site is in bold.
The amplification conditions were described in Materials and Methods. The
calculated annealing temperature was 61°C. 1110 of the amplification reaction
was loaded on an agarose gel to check the amplification of the expected band.
10JlI of amplified DNA were digested with ApaI for 3 hrs at 37°C. After
inactivation of the enzyme for 15' at 65°C, the DNA was digested with XbaI,
appropriately modifying the ionic strength of the reaction. After 3 hrs at 37°C,
the double digested DNA fragment was extracted once with phenol-chloroform
to inactivate the enzyme, precipitated with EtOH absolute and NaCI 0.1M,
washed with EtOH 70%, and resuspended in 10JlI of TE 1x. 1II 0 of the
resuspension was loaded on an agarose gel to check the amount of the digested
DNA band.
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3.1.3c Ligation of 1.2 Kb ApaI/XbaI digested fragment to ApaI/XbaI
digested, dephosphorylated PGK-neo plasmid.
The ApaI/XbaI digested 1.2 Kb fragment was ligated to the ApaI/XbaI
digested, dephosphorylated PGK-neo plasmid. We used a molar ratio
plasmid:fragment of 1:3.
After dialysis, 1/3 of the ligation was used to transform competent XLlblue
cells. 24 colonies were inoculated in 5ml of LB + ampicillin, and allowed to
grow 2 hrs at 37°C. 5).il of each bacterial growth were analyzed by PCR in the
same condition used to amplify the 1.2 genomic fragment. 19 out of 25 colonies
were positive to the amplification of the 950 bp expected band. 10 positive
clones were allowed to grow in a larger volume of LB + ampicillin, and DNA
was extracted by mini preparation. DNA of all 10 minipreps was digested with
EcoRI; according the genomic map, an EcoRI site is present at the position 420
in the 1.6 Kb genomic fragment. The digestion with EcoRI of PGK-neo plus the
1.2 Kb fragment would result in a band of 950 bp. Such expected band was
present in all the DNA analyzed, but not in the EcoRI digested plasmid PGK-
neo, which was simply linearized. One colony, number 3, was chosen and
grown in a larger volume of LB + amp, to get a larger amount of DNA
recovered by midi preparation. The DNA recovered by a midiprep was used for
further check of the cloning. Plasmid was digested with different restriction
enzymes: ApaI, HindUI, NotI, Xbal. PGK-neo was also digested as control. The
restriction analysis confirm the presence of the 1.2 Kb fragment cloned in PGK-
neo: ApaI, Hindlll and XbaI linearized both the plasmids, but PGK-neo gave a
lower band (lower molecular weight); NotI cut the new plasmid, but not PGK-
neo, as expected. To confirm the cloning, DNA from colony 3 was sequenced,
using the following two primers:
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5' 3'
_universal forward primer pUC/M13 (17 MER): GTTTTCCCAGTCACGAC
5' l'
- primer PR 2: GTGGTGGCCTTCAACTTCTTCCGCAAGTTC
The two primers are localized as shown in Fig. 1.5. The first 5' nucleotide of
primer PR2 maps at nucleotide 1301 of the 1.6 Kb fragment (nucleotide 50
downstream the 5' end of exon B).
The sequencing analysis confirmed the presence of the 1.2 Kb fragment cloned
in ApaI/XbaI in PGK-l plasmid.
This new plasmid was named PCR-neo. Figure 1.5 summarizes the cloning
strategy.
3.1.4 The DNA plasmid p~ 1.3-tk
The P" 1.3-tk plasmid was built by A. Nori by using the PGK-tk plasmid from
one side, and the p~1.3 on the other side.
The strategy utilized will be briefly described.
3.1.4a PGK-tk plasmid
The PGK-tk plasmid (Fig. 1.6) was made by cloning in pGEM-7Zf(+) the 2740
bp EcoRI-HindIII fragment from pKJtk containing the PGK-tk cassette
(Tybulewicz et aI., 1991), to get a 5.7 Kb plasmid. The PGK-tk cassette has all
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the components necessary for the autonomal expression of the tk gene, that is
the murine PGK promoter and poly(A), and the coding portion of the tk gene as
an 1823 bp fragment from pMCltk (Tybulewicz et al., 1991).
The PGK-tk plasmid was digested with XhoI and NsiI, so as to excise the tk
cassette from the pGEM-7Z(f)+ plasmid. The fragment containing the tk
cassette was blunted by Klenow enzyme, followed by digestion with BamHI.
This procedure created a fragment with a blunt end from one side, and a
~BamHI end on the other side.
3.1.4b The pi11.3 plasmid
The pi1 1.3 plasmid was digested with SmaI, which created a blunt end, and
BamHI. So, the linearized plasmid presented a blunt end and a BamHI end
suitable for the tk cassette fragment ends.
The digested p~ 1.3 plasmid was ligated to the tk cassette fragment. The
cloning was checked by restriction enzyme analysis and sequencing, and the
new plasmid was named p~ 1.3-tk (Fig. 1.6).
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3.1.5 The DNA plasmid Cl
The targeting vector was built by using the PCR-neo plasmid from one side,
and the p~ 1.3-tk on the other side.
3.1.5a HindIII digestion of PeR-neo and p~ 1.3-tk
10Jlg of PCR-neo were digested with the restriction enzyme Hindlll for 3 hrs at
370C. The linearized plasmid was eluted from an agarose gel through the low-
melting agarose technique, step followed by dephosphorylation. After
inactivation of AP, precipitation with EtOH absolute and NaCI O.lM, and
washing with EtOH 70%, the linearized and dephosphorylated plasmid was
resuspended in a suitable volume of TE l x, DNA concentration was checked by
loading 1110of the resuspension on an agarose gel.
20Jlg of the p~ 1.3-tk plasmid were digested with Hindlll for 3 hrs at 37°C. The
Hindlll digestion separated a 8 Kb DNA fragment from the plasmid. The 8 Kb
fragment contains the 5.2 Kb HindUIlEcoRI genomic region plus the tk
cassette. The digestion was loaded on a low-melting agarose gel, the 8 Kb band
was eluted, and resuspended in a suitable volume of TE l x. DNA concentration
was checked by loading 1110of the resuspension on an agarose gel.
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3.1.5b Ligation of the 8 Kb DNA fragment to the linearized p~ 1.3-tk
plasmid
The HindIII digested 8 Kb fragment was ligated to the HindIII linearized,
dephosphorylated PCR-neo plasmid. We used a molar ratio plasmid:fragment
of 1:3. 113of dialyzed ligation was used to transform XLI blue competent cells.
14 colonies were inoculated in 5ml of LB + ampicillin, and allowed to grow 2
hrs at 37°C. 5~1 of each bacterial growth were analyzed by PCR using the
primers named PR 2 and PR 6, that map in the 5.2 genomic region, spanning a
70 bp portion of exon C (Fig 1.7). The first 5' nucleotide of PR 6 maps at the
position 68 downstream the first nucleotide of exon C, the first 5' nucleotide of
PR 31 maps at the position 1 of exon C. The orientation of the two primers is
shown in Fig. 1.7. These are the sequences of the two primers:
5'
PR6:GGGTCTTCAATTTCATGACCAATGCC
5' 3'
PR31:TGCTACCTCTTCCACATGTAC
The amplification conditions were described in Materials and Methods. The
annealing temperature was calculated at 52°C.
11 out of 14 colonies were positive to the amplification of a 70 bp band. 10
positive clones were allowed to grow in a larger volume of LB + ampicillin,
and DNA was extracted by mini preparation. DNA of all 10 minipreps was
digested with HindIII. 8 out of 10 minipreps contained the 8 Kb fragment,
separated from the plasmid by the HindIII digestion. One colony, number 7,
was chosen and grown in a larger volume of LB + amp, to get a larger amount
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of DNA, recovered by midi preparation. The DNA recovered by midiprep was
used for further check of the cloning. Plasmid was digested with different
restriction enzymes: ApaI, NotI, XbaI, Sad, EcoRI. PCR-neo was also digested
as control. The restriction analysis confirm the presence of the 8 Kb fragment
cloned in PCR-neo. In addition, the restriction analysis revealed that the 8 Kb
fragment was inserted in the right orientation. To confirm the cloning and the
orientation, DNA from colony 7 was sequenced. The sequencing analysis was
performed with different primers (Fig. 1.7), using both short and long runs:
- universal forward primer pUCIM13 (17 MER) (see above)
5' 3'
- universal reverse primer pUCIM 13 (17 MER): CAGGAAACAGCTATGAC
- PR 6 (see above)
5'
-PR2:GTGGTGGCTTTCAACTTCTTCCGAAAGTTCTAC
The new plasmid represented the complete targeting vector, and was named
pCl. The cloning strategy of the pCI construct is summarized in Fig. 1.7.
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To get a large amount of highly purified targeting vector pCI, DNA extraction
was performed starting from a large culture (500ml of LB + amp) and using
caesium chloride DNA extraction method.
3.1.6 Linearization of the plasmid Cl to be transfected into ES cells
Plasmid DNA to be transfected into ES cells must be linearized.
The NotI site, deriving originally from the oligonucleotide a of PCR-neo, was
used as unique site to linearize the targeting vector pC 1 (Fig. 1.7). Two
different aliquots of DNA were digested with NotI: 25Jlg and 50flg· The
digestion was allowed to proceed oln at 37°C, and then was checked loading
III 00 of the reaction on an agarose gel. After phenol-chloroform extraction,
precipitation with EtOH absolute and NaCI O.IM, and washing with EtOH
70%, the linearized C 1 was resuspended in a suitable volume of buffer to be
transfected into ES cells, as will be described (see below).
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3.2. Restriction map of murine RyR3 3' genomic region
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3.2.1 Introduction
Gene targeting experiments are based on a homologous recombination event in
which the targeted wild-type genomic region is substituted with the mutated
one contained in the targeting vector. One of the most important aspects of the
gene targeting experiments is to confirm that the desired genetic change has
occurred. Two methods are available to screen for a specific recombination
allele: PCR or Southern blot analysis.
For PCR-based screenings, the primers are chosen to amplify a specific
junction fragment following a cross-over on the short arm of the vector.
Southern blot analysis is based on cutting genomic DNA with an appropriate
restriction enzyme, and choosing a probe that can distinguish the wild-type
from the predicted targeted allele. In order to avoid the identification of false
positives, two tricks are currently used:
_ a restriction digest with an enzyme that does not cut in the vector;
- the use of a probe that is not contained in the target vector.
As a consequence, a simple gene replacement event will increase the length of
the wild-type fragment by the length of the positive selection marker. So it is
easy to detect the integration of the entire vector by a significant increase of the
fragment size. The use of an enzyme that cuts inside the vector, together with
an external probe, allows the analysis of one arm of the target locus. Therefore
it is important to analyze both the 5' and the 3' of the target locus to be able to
discriminate a simple gene replacement event from the integration of the entire
vector or concatenamers of the vector.
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Internal probes detect also random integration events, which is the reason why
external probes are preferred.
The deep knowledge of the restriction map of the region interested by the
homologous recombination event results determinant
3.2.2 The 5' and 3' probes
The choice of the probes to be used in Southern blot analysis on mouse
genomic DNA was conditioned by the need of external probes. As a
consequence we decided to use the following genomic fragments:
5' probe: a 150 bp fragment just upstream the genomic region used to make the
targeting vector (Fig. 2.1);
3' probe: a 900 bp fragment immediately downstream the 3' end of the region
included in the targeting vector (Fig. 2.2).
3.2.2a The 150 bp as 5' probe
The chosen 5' probe maps in the 5' portion of the 1.6 HindIIIlHindIII genomic
fragment, that was cloned in pBluescript, producing the plasmid named pBS
HIH 1.6. This plasmid was used as template to amplify the 150 bp fragment to
be used as 5' probe (Fig. 2.3). The following primers were used:
5' 3'
primer d: TTGCCACACCTCAGGTACTGAGTC
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5'
primer c: GGCAAAGGTTGT AGGATCT ACCT ATGC
The first 5' nucleotide of primer d maps at the nucleotide 7 of the 1.6 H1H
fragment; the first 5' nucleotide of primer c maps at nucleotide 151 of the same
fragment.
The annealing temperature was 60°C.
The amplified 150 bp fragment was eluted from a low-melting agarose gel and,
after resuspension in a suitable volume of TE IX, it was used in a random
primed labeling reaction.
3.2.2b The 900 bp as 3' probe
The 900 bp EcoRIlHindIII fragment to be used as 3' probe had already been
cloned in pBluescript, producing the plasmid pBS EIH 0.9 Kb. The plasmid was
double-digested with the restriction enzymes EcoRI and HindIII. The 900 bp
DNA fragment, separated from the plasmid, was eluted from a low-melting
agarose gel, and, after resuspension in a suitable volume of TE 1x, it was used
in a random primed labeling reaction.
The strength of the two probes was checked in a Southern blot assay. Genomic
DNA from wild-type mice, extracted as described (see Materials and Methods),
was digested with HindIII and EcoR!. After Southern blot, DNA was
hybridized first with the 5' probe, the 150 bp fragment, and then with the 3'
probe, the 900
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Wild-type
HindIII
EcoRI HindIII
·~I+~-----... ~+I----------------------~--I -
exon B HindIlI
- 5' probe
150 bp
H H
1.6 Kb
Mutated allele
HindIIl exon B HindIIl
'I-I -+1 ----. neo cassette 1-1 -------------4----+-
EcoRI HindIII
- 5' probe
150 bp
H H
2.9Kb
Figure 2.1. The 150 bp long 5' probe just upstream the genomic region included in the
targeting vector pC 1. In the wild-type allele (top) the 5' probe recognizes a 1.6 Kb band
in Hindlll digested genomic DNA. In the mutated allele (bottom), a 2.9 Kb band is
identified.
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Wild-type
HindIII EcoRI HindIlI
5'probe
8.0Kb SpeI
SpeI
Mutated allele
exon B
SpeI
--~------~~111~----~~------------------------~--+-----~1HindIII SpeI HindIlI
EcoRI HindIlI
5'probe
9.3Kb SpeI
SpeI
Figure 2.2. The 900 bp long 3' probe just downstream the genomic region included
in the targeting vector pCl. In the wild-type allele (top) the 5' probe recognizes a 8.0
Kb band in SpeI digested genomic DNA. In the mutated allele (bottom), a 9.3 Kb
band is identified.
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pBS H/H 1.6
1.6 kb
exon B pBluescript
primer d..
primer c
amplification by peR
_ 5'probe
150 bp
Figure 2.3. The 5' probe derives from the amplification of 150 bp from pBS
WH 1.6 as indicated. Primers d and c were used for the amplification.
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Figure 2.4. Southern blot analysis on mouse genomic DNA digested with the
indicated restriction enzymes, and hybridized with the5' external probe 0.15 Kb
fragment.
4.5 Kb •
• 6.1 Kb
Figure 2.5. Southern blot analysis of mouse genomic DNA digested with the
indicated restriction enzymes, and hybridized with the 3' external probe 0.9 Kb
fragment
...... S.OKb
...... S.OKb
...... 4.0Kb
...... 2.0Kb
Figure 2.6. Southern blot analysis of mouse genomic DNA digested with different
restriction enzymes and hybridized with the 3 I probe. The different sized bands
recognized by the probe allow to draw the restriction map of the region.
The size of some of the bands is indicated.
bp E/H fragment. These are the results of the Southern blot assays (Fig. 2.4. 2.5,
2.6):
HindIII digestion,S' probe: 1.6 Kb band, as expected;
EcoRI digestion,S' probe: 6.6 Kb band;
HindIII digestion, 3' probe: 6.1 Kb band, as expected;
EcoRI digestion, 3'probe: 4.5 Kb band;
The Southern blot assay is shown in Fig. 2.4 and 2.5.
If on one side this assay confirmed the functionality of the two probes, on the
other side it gave the first information about the restriction map of this genomic
region. The restriction map was further investigated, as described below.
3.2.3 Digestion of genomic murine DNA by restriction enzymes
Genomic DNA from wild-type mice was digested with the following restriction
enzymes:
DraII, Ncol, Sfil, Seal, Mlu, Not!, Spel, SphI, Xhol, Sacl, Xbal, Scal/Spel,
ScallEcoRI, SeallHindIII, SeaIlXbal, Seal/Sac!, SpeIlEeoRI, SpellHindlII,
Spel/Xbal, SpeI/Sac!
The digested DNA was assayed by Southern blot and hybridized with the two
probes. Figure 2.6 represents an example of this analysis. The resulting
restriction map is represented in Fig. 2.7.
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3.2.4 Restriction digestion chosen to distinguish between the wild-
type and the mutated form of RyR3 allele
Once the restriction map of the genomic region of interest was known, the
subsequent step was to choose the restriction enzyme that gives a different
restriction pattern between the wild-type and the mutant RyR3 allele, and that is
recognized by the used probe.
3.2.4a Differential restriction digestion recognized by the 5' probe
Mouse genomic DNA was digested by HindIII, assayed by Southern blot and
hybridized by the 5' probe, 150 bp fragment: the wild-type allele gives a 1.6 Kb
band, while the recombinant allele gives a 2.9 Kb band (Fig. 2.1).
3.2.4b Differential restriction digestion recognized by the 3' probe
Mouse genomic DNA was digested by SpeI, assayed by Southern blot and
hybridized by the 3' probe, 900 bp fragment: the wild-type allele gives a 8.0 Kb
band, while the recombinant allele gives a 9.3 Kb band (Fig. 2.2).
The restriction digestion by SpeI and the hybridization with the 3' probe 900 bp
EIH was further used to genotype mice, as described below.
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3.3. The making of RyR3-/- mouse
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The procedure is based on several sequential steps that can be so summarized:
_ transfection of the targeting vector into ES cells
_ selection of transfected ES cells with G-418 and gancyclovir
_genotype analysis of selected clones by Southern blot assay
_injection of positive clones into mouse blastocysts for the production of
chimeras
_proper crossbreeds to obtain heterozygous mice for RyR3, and, subsequently,
homozygous mutant mice for RyR3.
3.3.1 Introduction
ES cell lines derive directly from embryo. This derivation was an extension of
the study on the stem cells of teratocarcinomas. The latter are tumors of germ
cells, and are most prevalent in the testes of 129 mice and in the ovaries of LT
mice. On this line of study, Stevens developed substrains of 129 mice with
enhanced rates of germ cell tumor formation (Stevens, 1983). As a
consequence, these strains were chosen in the first attempts to derive embryonic
cell lines (Evans and Kaufman, 1981). The method was extended to other
strains, but the 129 ES cell lines remain the most used. There is, however, a
certain degree of heterogeneity in ES cell lines, because in deriving these lines
different 129 substrains were used.
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We used two different ES cell lines:
ES cell lines Substrains
E14
Rl
129/01a
(129/Sv x 129/SvJ)Fl
All of the ES cell lines in common use were derived from male embryos. Male
ES cells are preferred because they produce a high proportion of phenotypic
male chimeras, and male chimeras can be bred quickly to test for germ line
transmission. Also in combination with a female embryo, male cells often
produce a fertile male chimera. This sex conversion is probably due to the
colonization by XY ES cells of various tissues determining sex in the
developing embryo. However, germ line transmission from female chimeras
has been reported in the literature, probably due to the loss of part of all the Y
chromosome; the resulting XO cells are able to form ova (Papaioannou V. and
Johnson, R., 1993). The positive, recombinant clone will be injected into a
mouse blastocyst. ES cells will contribute to the embryo, giving rise to a
chimera. The choice of the host embryo is determinated by two specific,
fundamental requirements:
_high probability of chimera formation (compatible host)
_difference in some genetic loci, useful as genetic markers to know the
contribution of injected ES cells to the whole animal.
C57BL/6J mouse embryos are compatible hosts for 129 ES cells. They
guarantee an efficient chimera formation and germ line transmission. C57BL/6J
mice differ from 129 mice in several genetic loci which are useful as markers of
chimerism. One of the best genetic marker of chimerism is represented by the
coat colour. Chimeric combinations of strains differing at coat colour loci allow
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a simple visual appreciation of proportion of the coat that expresses the ES cell
allele. In general, the more is the degree of coat colour chimerism, the more is
the contribution of the ES cells to the germ line. The difference in some coat
colour loci between the ES cell strains and the C57BL/6J strain make the last
one particularly suitable as host recipients embryos.
The following table summarizes the differences in coat colour alleles between
the ES cell strain used and the C57BL/6J strain:
Substrain ES cell line Locus Locus Locus
Agouti Albino Pink-eyed
dilution
129/0la E14 AW cch l p
(129/Sv x Rl AW c/+c p/+P
129/SvJ)Fl
C57BL/6J a +c +p
The following table demonstrates the phenotypic effects of the alleles in the
mentioned loci (from Papaioannou and Johnson, 1993):
Locus Alleles Cell type affected and
phenotypic effect
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Affect melanocytes;
a reduced
p
Affects hair follicle
function, alleles differ in
the amount and
distribution of yellow
pigment; wild-type (Aw
or A) hair has a yellow
sub-apical band
Pink-eyed dilution
AW, A, a, aeAgouti
Albino c,cch Affects melanocytes;
homozygous albino (ctc)
will mask any other coat
colour allele; cch causes
a reduced pigmentation
and affects yellow
pigment more than
black; ctcch IS
intermediate between c/c
and cch/cch.
causes
pigmentation but affects
black pigment more than
yellow.
In summary, a C57BL/6J blastocyst produces a black-coated mouse, a 129
mouse will be brown-coated, due mainly to the alleles in the Agouti locus.
Chimeras from C57BL/6J blastocysts plus injected ES cells will be
characterized by a mosaic of black regions and brown regions. The level of
chimerism will determine the extension of brown colour.
116
To get germline transmission is necessary that injected ES cells contribute to
the germline. To check it, sexually mature chimeric mice (60 days old) were
crossbred to C57BL/6J mice. If ES cells contribute to the germline, mice will
be heterozygous in the locus Agouti (Aw/a): the dominant allele Aw determines
the formation of brown-coated mice. If ES cells do not contribute to the
germline, both alleles at the locus Agouti are from C57BL/6J (ala), determining
black-coated mice.
Once heterozygous mice for RyR3 (RyR3+/-) have been identified, they were
crossbred with each other to get homozygous mice (RyR3-/-).
3.3.2 ES cell proceeding
These experiments were performed with the collaboration of Catherine Ovitt, at
EMBL, Heidelberg, Germany.
3.3.2a Transfection
Three rounds of transfection by electroporation of C 1 targeting vector into ES
cells were performed. As positive control, 10Jlg of linearized PGK-neo plasmid
were transfected into ES cells. As negative control, non-transfected ES cells
were used.
In the first experiment we used E14 ES cells. 25Jlg and 50Jlg of linearized DNA
were transfected into 107 cells. After G-418 and gancyclovir selection, 215
positive clones were identified. One clone out of 215 resulted positive by
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screemng for homologous targeting events by Southern blot analysis (see
below). It was named CI-134. The frequency of a homologous recombination
event was 0.4%.
In the second experiment we used Rl ES cells. 25J,1gof linearized Cl were
electroporated into 107 cells. Two out of 54 clones positive to 0-418 and
gancyclovir resulted positive by Southern blot analysis. They were C 1-9 and
C 1-49. With R 1 ES cells the frequency of homologous recombination was
3.7%.
In the third round of transfection both E14 and Rl ES cells were used. 50J,1gof
linearized Cl were transfected into 107 E14 cells. No positive clones were
selected. 25J,1gand 50J,1gof linearized Cl were transfected into 107 Rl cells.
Two clones out of 119 positively selected contained the mutated allele as the
result of a homologous recombination event. They were C 1-112 and C 1-116.
The frequency of recombination was 1.6%.
In all, five ES cell clones heterozygous for the mutated form of RyR3 were
identified, one E14 ES cell clone, four Rl ES cell clones.
3.3.2b Screening for homologous targeting events by Southern blot
analysis
Colonies that survived positive-negative selection were screened by Southern
blot analysis for the recombination allele. These screenings were performed on
the small amount of DNA obtained from cells grown in 96-well plates. An
aliquot of DNA from resistant clones was firstly digested with SpeI and assayed
with the 3' external probe EcoRIlHindIII 0.9 Kb fragment. The clones in which
an homologous recombination event had occurred gave two different bands: the
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wild-type 8.0 Kb band and the 9.3 Kb band from the recombinant allele (Fig.
3.1). A second aliquot of DNA from the positive clones was digested with
HindIII and analyzed with the 5' external probe 0.15 HindIII/HindIII fragment.
The real positive clones gave the wild-type 1.6 Kb band plus the 2.9 Kb band
from the recombinant allele (Fig. 3.2).
Figure 3.3a shows the result of the homologous recombination event, together
with the 3' probe and the difference of SpeI digestion between the wild-type
and the mutated allele.
119
+1+
+1+ +1+
+1+ +1+
+1+ +1- +1+
.._ 9.3Kb
._ 8.0Kb
,<
Figure 3.1. Southern blot analysis of genomic DNA digested with Spel. The 3'
external probe 0.9 Kb fragment was used. The wild-type clones (+/+) originates
the 8.0 Kb band, the heterozigous clone (+/-) gives the 8.0 wild-type band and the
9.3 Kb band from the recombinant allele.
+/- +/-
~ 2.9Kb
._ 1.6Kb
Figure 3.2. Southern blot analysis of genomic DNA digested with HindIII
The 5' external probe 0.15 Kb fragment was used. The heterozigous clones
(+/-) originate the wild-type 1.6 Kb band and the the 2.9 Kb band from the
recombinant allele.
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Figure 3.3. Gene targeting of the RyR3 locus. a) Wild-type allele (top),
targeting vector (middle) and the homologous recombination product (bottom).
H: HindIII site; E: EcoRI site. Exons are represented by black boxes. b)
Southern blot analysis. Genomic DNA was digested with SpeI and hybridized
with the 3' probe. The wild-type and mutated allele result in a 8.0 Kb and 9.3
Kb band respectively. In heterozygous both are present. c) Immunoblot
analysis. Diaphragm microsomes from +l+, +/- and .t: mice were analyzed by
western blot with RyR3-specific antibody.
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3.3.2c From the heterozygous ES cells to the chimeric mice
Two out of five heterozygous ES cell clones were injected into mouse
blastocysts from C57 black/6J strain. We chose the unique E14 positive clone,
CI-134, and the Rl positive clone CI-49.
The injections were performed in four different days.
I day: CI-134 ES cells at passage number p8 were injected in a total number of
9 blastocysts, recovered by C57 donor mothers as described (see Materials and
Methods). They were transferred to one COl foster mother. Unfortunately, no
pups were born, probably as the injected blastocysts did not survive.
II day: C 1-134 ES cells at passage number p8 were injected in a total number of
23 blastocysts. They were transferred to two CD 1 foster mothers. Four pups
were born. Three pups revealed to be chimeras. They were called CI-2-1, CI-2-
2, CI-2-3.
III day: CI-134 ES cells at passage number p3 were injected in a total number
of 14 blastocysts. They were transferred to two COl foster mothers. Two pups
revealed to be chimeras. They were named CI-3-1, CI-3-2.
IV day: CI-49 ES cells at passage number p4 were injected in a total number of
23 blastocysts. They were transferred to two CD 1 foster mothers. One pup
resulted to be a chimera. Itwas named C 1-4-1.
We got six chimeras in total.
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3.3.3 From chimeras to homozygous mice for the mutated RyR3 allele
(RyR3-1-)
Among the six chimeras, five were male, as expected, while Cl-2-3 was
female. All six chimeras were mated to C57BL/6J mice. Four chimeras gave
germ line transmission, revealed by brown-coated pups.
These results are summarized in the following table:
Clone chimera sex degree of germline
chimerism transmission
CI-134 CI-2-1 male 75% yes
CI-134 CI-2-2 male 95% no
CI-134 CI-2-3 female 100% yes
CI-134 CI-3-1 male 60% yes
CI-134 CI-3-2 male 100% no
CI-49 CI-4-1 male 90% yes
The four chimeras were renamed with alphabetical letters as follows:
Cl-2-1=A
Cl-2-3=B
Cl-3-1=C
Cl-4-1=D
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Pups from the crossbreed chimera x C57BL/6J were allowed to grow. When
they were 15 days old, the tip of the tails were cut, DNA was extracted,
digested with SpeI and the Southern blot analysis was performed using the 3'
external probe EcoRIlHindIII 0.9 Kb fragment. Mice heterozygous for the
mutated RyR3 allele were identified because of the presence of two bands from
the Southern blot assay: the wild-type 8.0 Kb band and the 9.3 Kb band from
the recombinant allele. These RyR3+1- mice were allowed to grow, and, when
sexually mature, they were crossbred to get homozygous mice for the mutated
RyR3 allele. Mouse DNA was analyzed by Southern blot assay as described
above. RyR3-1- mice could be identified for the presence of the only
recombinant 9.3 Kb band (Fig. 3.3b).
3.3.4 The RyR3-1- mouse
RyR3-1- mice were obtained in the 25% of the progeny, according to the
mendelian genetics. Their embryonic development was normal, as well as the
post-natal life. They could not be distinguished from wild-type mice. RyR3-1-
mice were allowed to grow until they reached sexual maturity, and then were
crossbred. They could give progeny as well as wild-type mice. We took
advantage of the non-sterility of the RyR3-1- mice to establish a RyR3-1- mouse
line. The line was established using mice of the group A.
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3.3.5 The control of RyR3 knockout mouse: looking for RyR3 mRNA
and protein
3.3.5a RyR3 mRNA in the RyR3-1- mouse.
We proceeded in parallel with both RyR3-/- mice and wild-type rmce as
control. Total RNA was extracted from adult mouse diaphragm. An amount of
10J.lgwas used for RT-PCR reaction. 5J.lIof synthesized cDNA was amplified
using the oligonucleotides, eI and fl. These two primers amplify a 290 bp long
fragment at the 5' of RyR3 eDNA.
These are the sequences of eI and fl primers:
5' 3'
eI: CGGAATTCGAGGGAGGCGAGGACGAGATCCA
5' 3'
fl:CCCAAGCTTCCTGTGGCCACCCCCTTGTGC
A 290 bp was amplified by both cDNA from control mice and cDNA from
knockout mice (not shown). The presence of the 290 bp fragment, that is the
presence of RyR3 mRNA in knockout mice, was not an unexpected result. In
fact the RyR3 gene was interrupted in its 3' portion, and, unless a strong
instability due to the interruption, mRNA should be synthesized. Evidently
RyR3 mRNA was not unstable.
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3.3.Sb RyR3 protein in the RyR3-1- mouse.
In order to determine if RyR3 protein had been knocked out, Western blot
analysis was performed on diaphragm and brain microsomes from RyR3-1- and
wild-type mice as control. Using the anti-RyR3 antibody, the band
corresponding to RyR3 monomer was absent in RyR3-1- mice, confirming the
positive outcome of the knockout technique (Fig. 3.3c).
RyRl and RyR2 antibodies were also used as control: the absence of RyR3
does not affect the expression of RyRl and RyR2 isoforms in Western blot
assay (see below, Fig. 4.2).
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Chapter 4
Pattern of expression of Ry R3 protein in adult skeletal muscle and
during neonatal phase of skeletal muscle development
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These experiments were performed together with Antonio Conti, researcher in
my same laboratory, Growth Factors and Signal Transduction Unit, DIBIT,
HSR.
4.1 Introduction
As described in the introduction, preliminary results about RyR3 expression in
adult mouse tissues had revealed a wide spread distribution of mRNA, without
an apparent preferential localization in a specific tissue or cell type (Giannini et
al., 1995). However, the presence of RyR3 mRNA and protein in skeletal
muscle together with the type 1 isoform resulted to be particularly interesting.
The presence of RyRI in skeletal muscle has been largely studied, and its role
in e-c coupling is universally accepted. Previous results revealed the expression
of RyR3 protein in such specific skeletal muscles as diaphragm and soleus
(Conti et al., 1996). In addition, RyR3 seems to be regulated during mouse
diaphragm development, because of the higher level of expression in 5 day old
mice diaphragm than adult tissue, as revealed by Western blot experiments on
mouse diaphragm (Tarroni et al., 1997). As described in details in the
introduction, the first 3-4 weeks after birth represent a critical phase for skeletal
muscle development: during this phase many muscle-specific proteins start to
be expressed, or switch from one isoform to another; the e-c coupling
machinery completes its structural and functional development after birth.
Because of the key role of this period for skeletal muscle development, and the
described preliminary results, we decided to further investigate the profile of
RyR3, and also RyRI and RyR2, in the neonatal phase of development.
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4.2a Western blot assay on microsomes from total hindlimb muscles
Western blot assay was performed as described (see Materials and Methods).
20J.lgof microsomal vesicles from total hindlimb mouse muscles were used in a
Western blot assay with the anti-RyR3 policlonal antibody. Muscles for
microsomal preparation were dissected from mice at different stages of
development: 18 days of foetal development (FI8), 2 day-old mice, 5 day-old,
25 day-old, adult mice. The same experiment was performed in parallel to
investigate RyRI and RyR2 expression with the suitable anti-RyR policlonal
antibodies, using 3J.lg and 50llg of microsomal vesicle preparation,
respectively. SERCA (Ca2+-ATPase) was used as control. RyR3 was weakly
expressed at FI8, increased at 2 day-old and reached the highest level of
expression at 15 day-old. Then the expression decreased (25 day-old) and
disappeared in the adult. Unlike RyR3, RyRI was expressed at progressively
higher levels from F18, reaching the peak of expression in the adult. RyR2 was
absent as expected (Fig. 4.1A).
The experiment confirmed a regulated expression of RyR3 during the neonatal
phase of skeletal muscle development, evidencing the maximum level of
expression in 15 day-old mice.
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Figure 4.1. Developmental expression of RyRs isoforms in skeletal muscles.
A) Western blot on microsomes from total hindlimb muscles of day 18 embryos
(lane 1), 2-day-old (lane 2), 5-day-old (lane 3), 15-day old (lane 4), 25-day-old
(lane 5) and adult mice (lane 6). Specific antibodies to distinguish the three
isoforms were used. SERCA (Ca2+-ATPase) was used as control. B) Western
blot analysis on microsomes from single skeletal muscles from 15-day-old and
adult mice: tibialis anterior (lanes 1 and 2), biceps femoris (lanes 3 and 4),
quadriceps femoris (lanes 5 and 6), extensor digitorum longus (lanes 7 and 8),
abdominal (lanes 9 and 10), soleus (lanes 11 and 12), and diaphragm (lanes 13
and 14).
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4.2b Western blot assay on microsomes from single muscles
Western blot assay was performed on nucrosomes from different mouse
muscles: tibialis anterior, biceps femoris, quadriceps femoris, extensor
digitorum longus (EDL), abdominal, soleus and diaphragm. RyRs expression
was analyzed from 15 day-old and adult mice. 20/lg, 3/lg and 50llg of
microsomal vesicle preparation were used to detect the expression of RyR3,
RyRl, and RyR2, respectively. The experiment confirmed the developmental
regulated expression of RyR3: RyR3 was expressed in all muscles from 15 day-
old mice, while in the adult the expression was only detectable in diaphragm
and soleus. Unlike RyR3, RyRl was expressed both in 15 day-old and in adult
muscles. RyR2 was absent (Fig. 4.1B).
The peak of RyR3 expression in 15 day-old skeletal muscle is not a feature of a
specific muscle, but is extended to all those analyzed.
4.3 Expression of the RyRl and RyR2 during development in
RyR3-1- mouse
In order to verify if the lack of RyR3 could affect the level of RyRI and RyR2
expression during skeletal muscle development, Western blot assay was
performed on micro somes from 5 day-old, 15 day-old and adult skeletal
muscles. Total hindilimb muscles and diaphragm were chosen. While the
absence of RyR3 in the assayed muscles was confirmed, RyRI and RyR2
expression was unaffected: RyRI was expressed at higher levels in adult
muscles than in 2 day-old and 5 day-old tissues, RyR2 was still absent (Fig.
4.2).
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The pattern of expression the two other isoforms did not result to be modified
as a consequence of the lack of type 3.
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Figure 4.2. Immunoblot analysis of RyR1, RyR2 and RyR3 from wild-type
(lanes 1, 3, 5, 7, 9, 11) and RyR3-/- mice (lanes 2, 4, 6, 8, 10, 12) at different
developmental stage: 2-day-old (lanes 1-4), 5-day-old (lanes 5-8), and adult
mice (lanes 9-12). Microsomes were prepared from total hindlimb (lanes 1,2,5,
6,9,10) and diaphr'agm (lanes 3,4,7,8, 11, l2) muscles.
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Chapter 5
Functional analysis of RyR3-1- mouse
133
5.1 Contractile function analysis
These experiments were performed in collaboration with R. Bottinelli and C.
Reggiani at the Department of Human Physiology, University of Pavia.
In order to address the contribution of RyR3 to the excitation-contraction
machinery, we studied the contractile properties of skeletal muscles from wild-
type and RyR3-1- mice. The experiments were performed to investigate both the
contractile response to physiological electrical stimulation and to caffeine, an
activator of RyRs.
5.1a Analysis of contractile activity in response to electrical
stimulation
Muscle strips were dissected from diaphragm of neonatal (15 day-old) and
adult (60-90 day-old) mice, wild-type and RyR3-1-.
A high frequency stimulation (50 Hz) was applied and fused tetani were
evoked. No significant differences were evident between wild-type and RyR3-
/- mice, although the preparation from neonatal mice developed less tension
than the preparation from adult mice (Fig. 5.IA). The experiment was repeated
using a low stimulation frequency (0.1 Hz): in 15 day-old mice tension
developed during the twitch was significantly lower in RyR3-1- than in wild-
type mice (Fig. 5.lB): expressed as a fraction of tetanic tension (twitch/tetanus
ratio), it represented 0.23±0.03 in wild-type (n-10) and 0.15±0.01 in RyR3-/-
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(n= 10, P<0.05). The measurement of tension developed during unfused tetani
(5 and 10 Hz) confirmed the results. At higher stimulation rates, the difference
was cancelled by fusion and summation of the responses. Figure 5.1 (C and D)
summarizes the result: in 15 day-old mice (Fig. 5.1C) the tension developed in
unfused tetani was lower in RyR3-1- mice than in wild-type (force-frequency
curve shifted downward and rightward in mutant mice); in the adult (Fig. 5.1D)
the difference disappeared.
The time necessary to peak tension was investigated. The time course of the
twitch was age-dependent, in fact it became shorter in the adult muscles. No
difference was detectable between wild-type and RyR3-1- mice, neither in the
15 day-old nor in the adult mice (Fig. 5.lE).
The analysis of the contractile properties was repeated after removing
extracellular Ca2+. Tension developed after lowering Ca2+ concentration in the
perfusing medium was lower in neonatal than in adult muscles, but, again, no
difference was detectable between wild-type and RyR3-1- mice, both in the 15
day-old and in the adult mice (Fig. 5.1F).
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Figure 5.1. Contractile properties of diaphragm strips from RyR3+/+ (filled
symbols and columns) and RyR3-/- mice (empty symbols and columns) at 15
and 60 days. A) Tension developed during tetanic stimulation at 50 Hz. B)
Twitch/tetanus ratio at the stimulation frequency of 0.1 Hz. C) Force-frequency
relationships in diaphragm strips from 15-day-old mice. D) Force-frequency
relationships in diaphragm strips from 60-day-old mice. E) Time to peak
tension in twitch responses. F) Effect of Ca2+ removal expressed relative to
twitch tension in basal conditions. Means and standard errors of 10 neonatal
and 20-28 adult RyR3+/+ preparations, and 10 neonatal and 16-22 adult RyR3-
/- preparation. *P<0.05.
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5.1h Analysis of contractile activity in response to stimulation by
caffeine
As for previous experiments, muscle strips were dissected from the diaphragm
of 15 day-old and adult (60-90 day-old) mice, wild-type and RyR3-/-.
Tension development was induced by exposure to millimolar caffeine
concentration. In wild-type mice, at caffeine concentration> 10mM, 15 day-old
diaphragm strips developed much more tension than adult diaphragm strips; at
30mM caffeine tension induced was four times greater in neonatal than in adult
strips (Fig. S.2A, B, and C). In addition, the kinetics of tension development
was much slower in neonatal than in adult diaphragm strips: the time to peak
tension was 400-600 s in neonatal and -10 s in adult (Fig. 5.2A and B).
The large response to caffeine produced in neonatal diaphragm strips from
wild-type mice was completely abolished in neonatal diaphragm strips from
RyR3-1- mice (Fig. S.2A and B). No difference was detectable between adult
wild-type and mutant mice. The kinetics of tension development was not
altered in RyR3-1- mice compared to wild-type, both in neonatal and in adult
mice. The abolishment of the large response to millimolar caffeine in RyR3-1-
diaphragm strips was the most important difference between wild-type and
RyR3-1- muscles.
These experiments were also performed in EDL and soleus muscles (not
shown). The difference of the responses to caffeine between preparation from
15 day-old wild-type and RyR3-1- mice was confirmed: in EDL 51% of tetanic
tension was measured in wild-type and 7.4% in mutant mice; in soleus 38% of
tetanic tension was measured in wild-type and 8.6% in mutant mice. In EDL
from adult mice the tension developed in response to caffeine was barely
detectable, and ranged between 5 and 10% in soleus. No difference between
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wild-type and RyR3-/- mice was detected, confirming the results obtained with
diaphragm.
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Figure 5.2. Response to caffeine of diaphragm strips from 15-day-old
(neonatal) (A) and 60-day-old (adult) mice (B). Diaphragm strips were exposed
to 30mM caffeine. Tension is expressed as the percentage of tetanic tension.
Arrows indicate addition and washing out of caffeine. C) Tension developed in
contractures elicited by exposing muscle strips to 10 and 30mM caffeine.
Means and standard errors of 10 neonatal and 30 adult RyR3+1+ preparations,
and 10 neonatal and 30 adult RyR3-1- preparations. Circles: neonatal mice;
squares: adult mice; filled symbols: RyR3+1+; empty symbols: RyR3-1-.
*P<O.05.
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5.2 Biochemical characterization of knockout RyR3-/- mouse
140
S.2a Introduction
The biochemical characterization of skeletal muscles from RyR3-/- mice was
performed through binding experiments on microsomal preparations from total
hindlimb and diaphragm muscles.
Binding analysis was performed by the use of the specific [3HJ-labeled ligand
ryanodine, which interacts with the channel in the open state.
Because of the specific interaction between the radiolabel led ryanodine and
ryanodine receptors, the binding assay was used as a tool to quantify the
amount of ryanodine receptors in the analyzed skeletal muscles. In fact, the
availability of RyR3-/- mice gave the possibility to compare binding data from
wild-type skeletal muscles to binding data from RyR3-/- skeletal muscles,
estimating the contribution of RyR3 to the total amount of ryanodine receptors
in the skeletal muscles analyzed.
Finally, binding experiments were performed on skeletal muscles from mice at
different developmental stages: 5 day-old, 15 day-old, and adult mice. By the
profile of expression of ryanodine receptors in skeletal muscles (RyRI and
RyR3) during neonatal development, it was interesting to study the same profile
by binding experiments, again taking advantage of the comparison between
RyR3+/+ and RyR3-/- mice.
To evaluate the amount of ryanodine receptors in the skeletal muscles, we
chose experimental conditions that are known to stimulate the maximum
binding of ryanodine, such as high salt concentration (lM KCI), and I0011M
Ca2+ (Ogawa and Harafuji, 1990; Murayama and Ogawa, 1996).
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5.2b Saturation experiments on microsomes from diaphragm and
total hindlimb of RyR3+/+ and RyR3-/- mice
Binding experiments were performed as described (see Materials and Methods).
Experiments on diaphragm from adult RyR3+/+ mice
Five experiments with four different batches of microsomes from adult wild-
type diaphragms were performed. The following table summarizes the results:
Ry I expo II expo III expo IVexp. Vexp. Media S.D.
(nM) _E_moleslm__g__j)_moleslll!&_ _lJ_moleslm2 _p_moleslmg _pmoleslm_g_ _pmoles/m_g_
2.5 0.18 0.24 0.26 0.49 0.59 0.35 0.173
3.5 0.25 0.55 0.61 0.47 0.038
5 0.39 0.42 0.6 0.74 0.72 0.57 0.147
6.5 0.52 0.69 0.67 0.63 0.014
7.5 0.72 0.45 0.68 0.89 0.9 0.73 0.211
8.5 0.84 0.78 0.8 1.03 0.86 0.136
10 0.68 0.87 0.77 0.76 0.98 0.81 0.103
12.5 0.67 1.1 0.99 0.89 1.21 0.97 0.138
15 0.82 1.17 0.96 0.86 0.95 0.158
17.5 0.82 0.84 0.86 0.84 0.014
20 1.08 1.42 0.93 0.99 l.1 0.267
25 1.66 1.49 1.11 0.95 1.3 0.277
30 0.76 l.28 1.06 1.33 1.93 1.27 0.372
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The resulting saturation curve and Scatchard plot analysis are shown in Fig.
5.3. The values of Kd and Bmax calculated were respectively 8.79 nM and 1.55
pmol/mg.
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Figure 5.3. Specific binding of [3H]ryanodine to diaphragm microsomal
membranes from +/+ mice. [3H]ryanodine binding in the presence of 2.5-30nM
[3H]ryanodine as indicated in Materials and Methods. Inset, Scatchard plot of
saturation data of the specific binding. Data represents the mean of 5
experiments in duplicate.
144
Experiments on diaphragm from adult RyR3-1- mice
Four experiments with three different batches of microsomes from adult
knockout RyR3-1- diaphragms were performed. The following table
summarizes the results:
Ry (oM) I expo II expo III expo IVexp. Media S.D.
pmoles/mg pmoles/mg pmoles/mg pmoles/mg pmoles/mg
2.5 0.07 0.16 0.15 0.13 0.13 0.036
3.5 0.09 0.14 0.11 0.031
5 0.12 0.18 0.28 0.41 0.24 0.126
6.5 0.31 0.26 0.28 0.04
7.5 0.31 0.25 0.26 0.49 0.33 0.114
8.5 0.36 0.26 0.31 0.071
10 0.3 0.46 0.2 0.48 0.36 0.133
12.5 0.37 0.43 0.39 0.041
15 0.38 0.54 0.24 0.38 0.152
17.5 0.32 0.37 0.34 0.034
20 0.35 0.43 0.48 0.42 0.069
25 0.27 0.54 0.4 0.19
30 0.2 0.72 0.79 0.55 0.56 0.264
The resulting saturation curve and Scatchard plot analysis are shown in Fig.
5.4. The values of Kd and Bmax calculated were respectively 10.7 nM and 0.7
pmol/mg.
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Figure 5.4. Specific binding of [3H]ryanodine to diaphragm microsomal
membranes from -/- mice. [3H]ryanodine binding in the presence of 2.S-30nM
[3H]ryanodine as indicated in Materials and Methods. Inset, Scatchard plot of
saturation data of the specific binding. Data represents the mean of four
experiments in duplicate.
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These results point out a strong difference between diaphragm from wild-type
and mutant mice. In particular, despite the similar values of Kd, the value of
Bmax from the RyR3-/- diaphragm was about half the wild-type diaphragm
Bmax, suggesting a strong contribution of RyR3 to the total amount of
ryanodine receptors in mouse diaphragm.
Experiments on hindlimb from adult RyR3+/+ mice
Two experiments with two different batches of microsomes from adult wild-
type total hindlimbs were performed. The following table summarizes the
results:
Ryanodine I expo II expo Media S.D.
(oM) pmoles/mg pmoles/mg pmoles/mg
0.5 0.31 0.36 0.33 0.033
1.5 0.57 0.43 0.49 0.101
2.5 0.67 0.42 0.55 0.178
5 0.79 0.53 0.66 0.185
7.5 1.12 0.87 0.99 0.178
10 1.44 0.89 1.17 0.388
15 2.36 1.35 1.85 0.714
20 2.85 1.57 2.21 0.906
30 2.55 1.63 2.08 0.652
The resulting saturation curve is shown in Fig. 5.5. The preliminary calculated
values of Kd and Bmax were respectively 5 nM and 1.94 pmol/mg.
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Figure 5.5. Specific binding of [3H]ryanodine to total hindlimb microsomal
membranes from +/+ mice. [3H]ryanodine binding was performed in the
presence of O.5-30nM [3H]ryanodine as indicated in Materials and Methods.
Data represents the mean of two experiments in duplicate.
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Experiments on hindlimb from adult RyR3-/- mice
Two experiments with two different batches of rmcrosornes from adult
knockout RyR3-/- total hindlimbs were performed. The following table
summarizes the results:
Ryanodine I expo II expo Media S.D.
(oM) pmoles/m~ pmoles/mg pmoles/mg
0.5 0.27 0.26 0.27 0.011
1.5 0.38 0.44 0.41 0.043
2.5 0.48 0.45 0.46 0.026
5 0.71 0.81 0.75 0.072
7.5 0.98 0.99 0.98 0.008
10 1.08 1.26 1.17 0.123
15 2.82 1.82 2.32 0.707
20 3.45 1.82 2.66 1.105
30 3.93 1.65 2.78 1.613
The resulting saturation curve is shown in Fig. 5.6. The preliminary calculated
values of Kd and Bmax were respectively 9.1 nM and 2.55 pmol/mg.
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Figure 5.6. Specific binding of [3H]ryanodine to total hindlimb microsomal
membranes from .t: mice. [3H]ryanodine binding was performed in the
presence of O.5-30nM [3H]ryanodine as indicated in Materials and Methods.
Data represents the mean of two experiments in duplicate.
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Because of the low number of trials and the few batches utilized, the result of
binding experiments performed on microsomes of total hindlimbs from +/+ and
.t: mice are preliminary, as suggested by the large value of the standard
deviation (see S.D. in the tables). Although preliminary, the data suggest a
substantial equality between the wild-type and the mutant hindlimb muscles, as
if the contribution of RyR3 to the total amount of RyRs in adult hindlimb
muscles were minimum. This conclusion is in agreement with the Western blot
assays described (see above).
S.2c Ca2+ -dependence of [3H]ryanodine binding on diaphragm
microsomes from RyR3+/+ and RyR3-/- mice
Binding experiments were performed as described (see Materials and Methods).
The data presented are the result of preliminary experiments.
Experiments on diaphragm from adult RyR3+/+ mice
Two experiments with two different batches gave the following results:
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Ca2+ specific binding specific binding average value
pmol/mg pmoVmg in % relative to
I experiment II experiment the 100%
prnoles/mg pmoles/mg binding
10nM 0.054 / 4
100nM 0.297 / 22.5
IJlM 0.515 0.194 83.3
10JlM 0.593 0.194 89.2
100JlM 0.66 0.219 100
ImM 0.565 0.133 73.2
10mM nd 0.1212 55.3
100mM 0.04 0.034 3
The last column of the table represents the average values in % relative to the
100% of maximum binding. The peak of [3H]ryanodine binding was obtained
at Ca2+ concentration of 100JlM, as shown in Fig. 5.7.
152
+1+
120
100
- 80e......-=e 60~
~
40
20
0
8 7 6 5 4 3 2 1
pea
Figure 5.7. Dependence of [3H]ryanodine binding on Ca2+ concentration.
Experiments were performed on diaphragm microsomes from RyR3+1+ adult
mice.
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Experiments on diaphragm from adult RyR3-/- mice
Two experiments with two different batches gave the following results:
Ca2+ specific binding specific binding average value average value
pmoVmg pmoVmg in % relative to in % relative to
1 experiment II experiment the 100% the 100%
pmoles/mg pmoles/mg binding (I) binding (II)
10nM / 0.025 / 14.8
100nM 0.073 0.09 21.5 53.2
1JlM 0.34 0.124 100 73.4
10JlM 0.314 0.169 92.3 100
100JlM 0.319 0.148 93.8 87.6
1mM 0.187 0.112 55 66.3
10mM 0.013 / 3.8 /
100mM / / / /
The last 2 columns of the table represent the average values in % relative to the
100% of maximum binding. In this case, the 100% of [3H]ryanodine binding
was different in the two experiments. The curves of the single experiments are
shown in shown in Fig. 5.8 A and B. A larger number of experiments will help
to clear the picture.
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Figure 5.8 A and B. Dependence of [3H]ryanodine binding on Ca
2
+
concentration. Experiments were performed on diaphragm microsomes from
RyR3-1- adult mice.
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5.2d [3H]ryanodine binding experiments on microsomal
preparations from RyR3+/+ and RyR3-/- mice at
different stages of neonatal skeletal muscle development
r3Hlryanodine binding experiments on diaphragm
Microsomes from 5 day old, 15 day-old and adult diaphragm mice were utilized
in [3H]ryanodine binding assays. 4 experiments were performed using three
different batches for 5 day-old diaphragms, four different batches for 15 day-
old diaphragms and four different batches for adults.
Figure 5.9 schematizes the results reported in the following table:
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The value of [3H]ryanodine binding (pmol/mg) in 5 day-old diaphragm is
similar to the value in 15 day-old muscle, and again, very similar to the adult
value. From these data, it seems that no change in the total level of RyRs occurs
during neonatal diaphragm development, both in RyR3+/+ and in RyR3-/-
mice. Although the profile of [3H]ryanodine binding does not change, in
knockout RyR3-1- mice there is a strong reduction of the binding values (Fig.
5.9). As for the saturation experiments, these data suggest a strong contribution
of RyR3 to the total amount of RyRs in diaphragm during the analyzed
neonatal phases of development.
[3Hlryanodine binding experiments on total hindlimb
The same experiments described for diaphragm microsomes were performed on
microsomes from total hindlimb muscles. 6 experiments with three different
batches of 5 day-old, 15 day-old and adult hindlimb muscles were made. The
following table summarizes the results:
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Figure 5.10 shows the profile of [3H]ryanodine binding during neonatal
development of hindlimb muscles. At difference with the picture described in
diaphragm, [3H]ryanodine binding values (pmol/mg) increase progressively
during development, without any detectable difference between wild-type and
RyR3-1- mice.
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Figure 5.9. [3H]ryanodine binding during development of diaphragm muscle in
+/+ and .t: mice. Data represent the mean of four experiments in duplicate. For
each stage, the mean ± S.D. is represented.
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Figure 5.10. [3H]ryanodine binding during development of total hindlimb
muscles in +/+ and -/- mice. Data represent the mean of six experiments in
duplicate. For each stage, the mean ± S.D. is represented.
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Chapter 6
General discussion
161
6.1. Developmental pattern of expression of RyR3
The expression of the RyR3 isoform in mammalian skeletal muscle (Conti et al.
1996) opens the possibility of involvement of this Ca
2
+ channel in the e-c
coupling process regulating skeletal muscle contraction.
We performed an accurate analysis of RyR3 expression III mouse skeletal
muscle from the late phase of foetal development throughout neonatal and
adult stages.
RyR3 protein is expressed at 18 days of foetal development, and at difference
with RyRl, reaches the highest level of expression between 2-3 weeks after
birth. Then it decreases and disappears in all adult muscles with the exception
of the diaphragm and the soleus, confirming the previous results (Conti et aI.,
1996).
The relevance of RyR3 expression in the neonatal phase of skeletal muscle
development can be understood in the light of the importance of the neonatal
phase for the development of skeletal muscles.
The neonatal stages represent a crucial period for skeletal muscle development.
By the first 3-4 weeks after birth, skeletal muscles undergo a series of
morphological and biochemical changes that allow them to reach a complete
structural and functional maturity. This process involves both the contractile
components of muscle fibers and the constituents of the Ca
2
+-release units. One
of the best known examples of changes in isoform profile of contractile proteins
is the switching from the embryonic to the adult myosin heavy chain (MHC)
isoforms: in the rat hindlimb muscles foetal fibers express the embryonic and
neonatal isoforms of MHC; during the first weeks of neonatal development
they switch to four major isoforms, the MHC ~/slow isoform and the three
adult fast MHA (MHC-2A, 2B. and 2X), normally repressed during earlier
developmental stages (Schiaffino and Reggiani, 1996). The transcripts of these
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four different isoforms are differentially distributed III different fibers and
muscles.
The development of the Cai'-relcase unit and transverse tubule network has
been well characterized in chicken skeletal muscle fibers (Takekura et al.,
1994). The correct assembly of the main components of the membrane system,
that is the feet (RyRs), the tetrads (DHPRs) and the internal protein associated
with the junctional surface of the SR (calsequestrin), occurs in different
sequential steps. First, in parallel with early myo-fibrillogenesis, the Ca
2
+-
release unit completed with feet, tetrads and internal proteins assembles at the
periphery of the muscle fibers, generating the "peripheral coupling". The t-
tubules are not present yet. The second step includes the appearance of a
complex T-tubule network, which is not transversally oriented yet, but runs
longitudinally. The final stage of maturation of these two-membrane systems
involves the rearrangement of T-tubules and triads from a longitudinal to a
transversal orientation, and localization of triads at the A-I junction or Z line.
The coordinated maturation of these two-membrane systems occurs in the
neonatal phase of development, that is up to 4 weeks in chick (3 weeks in rat
and mouse) (Franzini-Armstrong, 1996).
The highest level of expression of RyR3 isoform coincides with the structural
and functional maturation of the skeletal muscles, even though it is not clear
why neonatal muscles requires high levels of RyR3 compared to adult.
6.2. Impairment of contractile activity in skeletal muscles from
neonatal knockout mice.
The involvement of RyR3 in e-c coupling mechanism during the neonatal phase
of muscle development is confirmed by the knockout of the murine RyR3 gene.
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The analysis of the contractile activity of the skeletal muscle from RyR3-1-
mice reveals an impairment during the first weeks after birth. In agreement with
the preferential expression of this isoform in the post-natal period of
development, skeletal muscles are about 35% less efficient in translating the
electrical stimulation into force generation. Such impairment disappears in the
adult diaphragm, still expressing RyR3. The strong reduction in the force of
contraction in RyR3-1- muscles represents the first evidence of RyR3
involvement in the e-c coupling machinery for skeletal muscle contraction. The
impairment in the skeletal muscle contraction activity is even evident when
muscles from neonatal RyR3 knockout mice are treated with high doses of
caffeine (30mM), a well-known activator of Ca2+-release through RyRs: the
contracture was reduced to about 20% compared to control mice. The
significant reduction in the response to caffeine is also in agreement with the
results obtained with RyRI knockout mice (Takeshima et aI., 1994), in which
skeletal muscles lacking RyRl isoform still respond to high doses of caffeine
(mM range), feature attributed to the presence of RyR3 isoform.
The impairment in the force generation in neonatal RyR3-1- skeletal muscles
both after electrical stimulation and caffeine stimulation strongly suggests the
involvement of RyR3 in a secondary component of Ca2+-release in the e-c
coupling process. According to this hypothesis, RyR3 would work through a
Ca2+-induced Ca2+-release mechanism contributing to the amplification of the
signal: the depolarization of the plasma membrane elicits activation of RyRl,
via mechanical coupling with DHPR; subsequently, Ca2+-release through RyRI
stimulates RyR3 via CICR, determining an amplification of the signal (Fig.
6.1).
Our results strongly support a current model of e-c coupling machinery in
skeletal muscle contraction originally proposed on the basis of morphological
studies on non-mammalian vertebrate skeletal muscles (Block et aI., 1988), but
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then further supported by biochemical studies, physiological analysis, and
finally, our data. According to this model, two functionally different
populations of RyRs co-exist in skeletal muscle, and may be involved in the
regulation of skeletal muscle contraction. Electron microscopy analysis
revealed an ordered array of RyRs and DHPRs, with only one in every two
Ca2+-release channels on the SR facing the voltage sensor on the t-tubule (Block
et aI., 1988). This structural organization has been observed in muscles of non-
mammalian and mammalian vertebrate containing only one RyR isoform
(O'Brien et aI., 1993; Franzini-Armstrong and Kish, 1995), suggesting that this
alternating array may be a general motif in vertebrate skeletal muscles but that
two different RyR isoforms are not always required. Physiological studies of
Ca2+-release from the SR revealed the existence of two components, a fast
activating and inactivating component of large amplitude, and a smaller more
steady component (Fleischer and lnui, 1989; Rios et aI., 1992; Meissner, 1994;
Schneider, 1994): initial voltage-dependent Ca2+-release by the latter component
would activate the former, representing the CICR component. RyRI isoform is
involved in the transduction of the signal from the plasma membrane to the SR,
probably via a mechanical coupling with the DHPR. The importance of RyRI
in skeletal muscle contraction mechanism has been confirmed by the lack of e-c
coupling in RyRI knockout mice (Takeshima et al., 1994; Nakai et al., 1996),
and by en/en mutant, a natural chicken mutant not expressing Ryk l/n, in which
the e-c coupling is abolished (Ivanenko et al., 1995). This specialized function
can not be performed by RyR3, because the e-c coupling mechanism can not be
restored
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Figure 6.1 Two-channel model of e-c coupling. The depolarization
of the plasma membrane triggers RyRl actvation via mechanical
coupling with the voltage sensor DHPR. Calcium released by RyRl
stimulates calcium release by RyR3 via CICR, determining an amplification
of the signal.
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in the knockout mice for RyRl, and it is absent in the natural chicken mutant
despite of the absence of RyR3/p. Thus, RyRI is the best candidate to cover the
role of the Ca2+ channel facing the voltage sensor. The arrangement of the two
different RyR populations with respect to the DHPRs is shown in Fig.6.2. In
most non-mammalian skeletal muscles, RyRI/a and RyR3/P are expressed in
the same amount, and can be organized as shown in Fig.6.2 A: RyRlIa is
represented by the white bulbs, each coupled to a tetrad; the black bulbs are the
RyR3/isoform in an alternate disposition with RyRl/a. Some non-mammalian
vertebrate skeletal muscles only express the RyRlIa isoform, like the
swimbladder and the extraocular muscles (extra-fast muscles), and most of
mammalian muscles do not express RyR3/p. In this case the arrangement could
be schematized as in Fig.6.2 B: RyRlIa isoform contributes both to the coupled
population of receptors and to the uncoupled. Fig.6.2 C represents the situation
in neonatal mammalian skeletal muscles, containing RyRI/a and lower level of
RyR3/p. RyR3-/- mice have a functional e-c coupling machinery, according to
the fact the contraction following electrical stimulation is controlled by
RyRI/a. However, the strong impairment in the response to both electrical and
caffeine-mediated stimulation suggests an involvement of RyR3/P in the e-c
coupling machinery. Therefore, in the neonatal stages of muscle development
RyR3/P uncoupled Ca2+ channels provide the amplificatory component of e-c
coupling apparatus, based on the CICR mechanism. We can speculate that the
presence of a more sensitive system for a CICR-mediated amplification might
be of particular relevance in neonatal muscles in view of the incomplete
development of the triad structure (Luff and Atwood, 1971; Flucher and
Franzini-Armstrong, 1996). This view is also supported by the fact that during
neonatal development a sequential use of CICR and DCCR occurs (see above
"Introduction").
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Fig.6.2 Schematic representation of the relative positions of RyRs and DHPRs
(tetrads) at triads of skeletal muscles. The DHPRs are on the upper line that
represents the t-tubule, RyRs are on the bottom line, that is the SR membrane.
The white and black bulbs represent RyRlIa and RyR3/~, respectively. A)
Skeletal muscle containing equimolar amounts of the two isoforms. B) Skeletal
muscle containing only RyRlIa. C) Skeletal muscle containing predominantly
RyRI/a and, at lower amount, RyR3/p.
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The data available about the amount of RyR3 in neonatal mammalian skeletal
muscles explain the ratio between RyRI and RyR3 in Fig. 6.2 C, with one
RyR3 (in black) among many RyRI (in white). If this is the relative amount of
the two isoforms, what accounts for the strong effect obtained with the lack of
such a few receptors in RyR3-/- mice?
The answer to this question represents a challenge for future directions. In
general what could accounts for the strong effect on skeletal muscle contraction
due to the lack of RyR3 is the amount of the protein, the intrinsic properties of
the channels, possible interactions with other proteins.
The data available about the amount of RyR3 in mammalian skeletal muscle
suggest that RyRI is the isoform predominantly expressed, while RyR3
contribution to the total RyRs is very low. In addition to our results on adult
and neonatal skeletal muscles (Conti et aI., 1996; Tarroni et aI., 1997, and this
study), biochemical evidences on mammalian adult diaphragm indicate that
RyR3 represents the 0.06% of the total RyR amount (Murayama and Ogawa,
1997). Recently, RyR3 isoform immunopurified from bovine diaphragm was
shown to represent <5% of total RyRs (Jeyakumar et aI., 1998). However, these
results are from adult diaphragm, and further analyses are necessary to establish
the relative amount of RyRI and 3 in the neonatal skeletal muscles.
Another interesting aspect concerns the possibility of a differential distribution
of RyR3 in diverse muscle fibers. Recently, immunolocalization analysis has
been performed at different developmental stages in muscles of wild-type and
RyR3 knockout mice, using isoform-specific antibodies (Flucher et al., 1999).
This study confirmed the high level of expression of RyR3 during postnatal
development, followed by a decrease in all muscle fibers at different rates in
different muscles: RyR3-positive fibers could be found in the adult diaphragm,
while in EDL RyR3 could not be detected as early as 25 days after birth.
Whenever RyR3 was expressed and it co-localized in the triad junction with
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RyRI in same fibers, supporting the idea of a role of RyR3 in e-c coupling
together with RyRl, but there were no evidences of any correlation of RyR3
expression with a specific fiber-type. Nevertheless, RyR3 expression in some
muscle fibers suggested a functional difference between fibers that contain
RyR3 in addition to RyRI and fibers that do not contain RyR3. Which is this
functional difference is not clear yet.
The intrinsic properties of RyR3 could explain RyR3-1- phenotype. The use of
RyR3 isoform for the uncoupled release channels is likely to reflect specific
regulatory properties of RyR3 that might make it more effective than RyR 1 in a
CICR mechanism. Such regulatory properties could be specific
activation/inactivation kinetics, or a peculiar sensitivity to Ca
2
+ or to other
regulators (agonists and antagonists). Recently, taking advantage of the
differential distribution of RyR3 in mammalian skeletal muscles and of the
RyR3 knockout mice, the single-channel properties of the native mammalian
RyR3 channel have been studied using SR vesicles (Sonnleitner et aI., 1998).
From this study, RyR3 reveals to have a lower sensitivity to inactivation at high
Ca2+ concentration than RyRl. We can speculate that RyR3 channels are
activated by the initial rise of Ca2+ concentration provided by the opening of
RyRl. The lower sensitivity of RyR3 channels to inactivation at high Ca
2
+
concentration could be important to maintain a sustained Ca
2
+ -release after
deactivation of RyRI (Rios et aI., 1992), providing, or, at least, contributing an
amplification component for Ca2+ -release from SR.
Many other factors could be involved in the regulation of RyR activity.
Interaction with other proteins could contribute to a differential regulation of an
isoform with respect to the other. As we have seen (see "Introduction"), RyRI
from rabbit skeletal muscles interacts with the small protein called FKBP12
exerting a stabilizing effect on the channel (Brillantes et aI., 1994). The
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question to be addressed is if the interaction with FKB 12 or other molecules
can affect RyR3 functional status, stabilizing the channel or changing its
behavior in response to modulators.
6.3. Biochemical characterization of knockout RyR3-/- mouse:
preliminary results.
The [3H]-ryanodine binding assay on microsomal fractions from RyR3-1- and
wild-type mouse skeletal muscle is a useful tool to address what is the amount
of RyR3 relative to RyRI in skeletal muscles.
The saturation curve experiments obtained from RyR3-1- and wild-type muscles
reveal a strong difference between diaphragm and hindlimb: while the
saturation curve from -/- and +1+mouse hindlimbs is substantially unchanged,
confirming the data from Western experiments, the value of Bmax from the
saturation curve on -1- mouse diaphragm is reduced half compared to the Bmax
from wild-type diaphragm. This picture is also confirmed by the binding
analysis during development, where no differences between mutant and wild-
type mice were detected, while 50% reduction was present in RyR3-1-
compared to RyR+I+ at 5 days and 15 days of postnatal development. The
discrepancy between the relative amount of RyR3 and RyRI in diaphragm and
the data from Western analysis (Conti et aI., 1996; Tarroni et al., 1997; this
study), together with the recent immunopurification of RyR3 from bovine
diaphragm (Jeyakymar et aI., 1998) has still to be defined.
Recent immunostaining experiments using isoform-specific antibodies on
diaphragm muscle from newborn and adult mice show that all fibers of
newborn mice express RyR3, while in adult diaphragm only a subset of 10 to
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15% contains RyR3 (Flucher et al., 1999). The developmental decrease in
RyR3 protein observed in adult diaphragm results from the reduced number of
RyR3 positive fibers. In this new light, the relative amount of RyR3 in skeletal
muscle fibers is higher than previously deduced from biochemical estimates
based on total muscle homogenates.
The preliminary results of Ca2+ dependence of [3H]-ryanodine binding on
diaphragm micro somes from RyR3-1- and wild-type mice reveal a slight but
significant difference: in the wild-type maximum activation is obtained at
100flM Ca2+ concentration, and binding is still detectable at lOmM Ca
2
+
concentration, a high threshold of inactivation. In the mutants, where only the
RyRI isoform is present, binding is not detectable at 10mM, revealing a higher
sensitivity to Ca2+ inactivation. Although further experiments are required to
confirm the data, they seem to agree with the recent data on single-channel
properties on native RyR3 isoform showing a low sensitivity of RyR3 to
inactivation at high Ca2+ concentration (Sonnleitner et al., 1998).
6.4. RyR3 contribution to Ca2+ sparks in embryonic and adult
mouse skeletal muscle.
The analysis of the kinetic behavior of Ca2+ sparks in a system lacking one of
the components of the e-c coupling machinery, either DHPR subunits or RyR
isoforms, should provide information on specific arrangements of DHPRs and
RyRs required for the e-c coupling.
In a recent study, Ca2+ sparks at resting potentials were examined in fast-twitch
intercostal muscles from late-gestation wild-type and RyR3 knockout mice, and
in fast-twitch muscle cells from the flexor digitorum brevis muscle of wild-type
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adult mice (Conklin et al., 1999b). Ca2+ sparks in embryonic RyR type3 null
myotubes were smaller, briefer and had a faster time to peak than sparks in
wild-type muscles of the same age. Sparks in adult cells were significantly
smaller than sparks in embryonic RyR type3 null myotubes. The small sparks
observed in the absence (RyR type 3 null muscles) or in the presence of very
low amount of RyR3 (adult myotubes), suggest a major contribute of RyR3 to
the larger and longer-lasting sparks in embryonic myotubes, containing large
amount of RyR3.
RyR3 and RyRI co-localize at junctional triads forming hybrid clusters in
which both the isoforms are present (Flucher et aI., 1999). In embryonic
muscle cells, the pool of RyRI not controlled by voltage combines with a large
pool of RyR3 which is also not controlled by voltage, increasing the density of
RyRs that could be activated by Ca2+. Such high density of Ca2+-activated RyR
channels could account for the large and long-lasting sparks in embryonic
muscle cells. The reason why the large amount of RyR3 would be responsible
for the sparks with larger parameters in embryonic myotubes could reside in the
ligand gating characteristics of RyR3 channels. In fact a long mean open time
has been reported in the mammalian RyR3 channel expressed in HEK293 cells
(Chen et al., 1997), and, in addition, mammalian RyR3 is characterized by a
low sensitivity to inactivation by Ca2+ (Sonnleitner et al., 1998). Therefore, the
sub-cellular localization on one side, and the ligand gating features on the other
side support the observation that RyR3 enlarges Ca2+ sparks.
The contribution of RyR3 to the formation of large sparks is in line with the
hypothesis of the requirement for a more sensitive system for a CICR-mediated
amplification mechanism of Ca2+release in neonatal skeletal muscle. As already
observed, in this phase of development triads are still immature, and a cardiac-
like e-c coupling mechanism (CICR) has been using. With the proceeding of
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development and the maturation of the triad systems the CICR mechanism is
substituted by a DCCR, and RyR3 levels in skeletal muscles strongly decrease.
Alternatively, RyR3 could be involved in different processes other than e-c
coupling. Some aspects of myogenesis could be influenced by Ca2+ sparks. An
example is represented by the block of spontaneous Ca2+ transients from RyRs
in Xenopus myocytes, that disrupts the assembly of myosin thick filaments (A
band) (Ferrari et al., 1998). In this respect, the separate contribution of RyR 1
and RyR3 in Ca2+ sparks was investigated using intercostal muscle cells from
RyR3 knockout and RyR1 knockout mouse embryos, respectively (Conklin et
al., 2000). Both isoforms showed the ability to produce Ca2+ sparks. As RyR3
null muscle cells exhibit a normal phenotype and RyR1 null muscle cells are e-
c uncoupled, Ca2+ sparks seem to result from the activity of small clusters of
RyRs regardless of the participation of these RyRs in the e-c coupling process.
However, any involvement of RyR3 in muscle developmental process is still to
be investigated.
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